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Fractional flow reserve is the current gold standard for evaluating severity of 
coronary artery disease, but it is underutilized clinically due to its invasiveness. Recent 
efforts have worked toward developing non-invasive alternatives, wherein medical 
imaging data are used to construct patient-specific computational fluid dynamics models 
to simulate blood flow through the coronary arteries and calculate virtual fractional flow 
reserve. Magnetic resonance imaging is particularly well-suited for this application due to 
its ability to directly quantify both angiographic geometry and flow velocity. Therefore, 
the purpose of this thesis was the investigation and development of magnetic resonance 
techniques toward defining the patient-specific boundary conditions needed in 
computationally estimating fractional flow reserve. 
In Aim 1, we performed a series of computational simulations to determine what 
patient-specific flow information is needed to calculate virtual fractional flow reserve. 
Then, we tested phase-contrast magnetic resonance in a cohort of healthy volunteers to 
validate its ability to quantify coronary arterial flow. In Aim 2, several novel 
implementations of self-gated magnetic resonance angiography were investigated for their 
ability to characterize coronary arterial geometry. Tests were carried out in several cohorts 
of adult patients with congenital heart disease and a cohort of pigs to study the use of self-
navigation and both four and five–dimensional golden-angle radial sparse parallel 
magnetic resonance. Optimizations of both the acquisition and reconstruction frameworks 
were explored. Altogether, these studies advanced the use of magnetic resonance 




CHAPTER 1.  CLINICAL BACKGROUND 
1.1 Coronary Artery Disease 
Coronary artery disease (CAD) is responsible for half of all deaths attributed to 
cardiovascular disease, making it a leading cause of death globally [1, 2]. In the United 
States, approximately 6.7% of adults age 20 and older have CAD [3]. The underlying cause 
of CAD is atherosclerotic lesions creating flow-limiting stenoses in the coronary arteries, 
which can result in downstream myocardial ischemia and potentially myocardial 
infarction. A primary catheter-based revascularization treatment for CAD is percutaneous 
coronary intervention (PCI), which includes angioplasty and deployment of a vascular 
stent (Figure 1). However, not all patients with CAD are at risk for myocardial infarction, 
Figure 1: Percutaneous coronary intervention.  (a) A catheter is used to position the ballon and stent at the 
site of narrowing. (b) The balloon in inflated, and the stent is deployed. (c) The catheter and balloon are 




and it is therefore important to be able to correctly identify which patients would benefit 
from intervention.  
Historically, CAD has been assessed through percent anatomic narrowing of the 
vessel lumen. Gould et al. first demonstrated the relationship between luminal narrowing 
and ischemia induction in 1974, but more recent studies have shown that anatomic severity 
of a coronary stenosis is not strongly predictive of its physiologic severity [4]. In 2007, the 
Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation 
(COURAGE) trial investigated patient outcomes following angiography-guided 
revascularization. It reported that of patients with ≥70% diameter stenoses, only 32% 
exhibited severe ischemia and as many as 40% displayed minor or no ischemia. 
Furthermore, it concluded that using angiography-guided PCI did not reduce the risk of 
death, myocardial infarction, or other major cardiovascular events when added to optimal 
medical therapy consisting of pharmacologic therapy and lifestyle intervention [5]. 
1.2 Fractional Flow Reserve 
In 1995, Pijls et al. introduced fractional flow reserve (FFR) as an index to evaluate 
the functional significance of epicardial coronary stenoses [6]. Theoretically, it is defined 
as the ratio of maximum flow through the stenotic vessel to maximum flow through the 
hypothetical healthy vessel. In clinical practice, it is determined by taking the ratio of 
pressure distal to the lesion to pressure proximal to the lesion during maximal hyperemia 
(Figure 2). Therefore, an FFR of 1.0 would indicate no reduction in flow while an FFR of 
0.5 would indicate a 50% reduction in flow. We expect the pressure to scale linearly with 




induction of hyperemia using an injected vasodilator—such as adenosine—and averaging 
measurements across multiple cardiac cycles [6]. 
Several studies have shown the benefits and efficacy of FFR in deciding who 
benefits from PCI. In 2007, the DEFER study investigated the effect of PCI in patients with 
functionally non-significant coronary stenosis, and found that there was no benefit to 
intervention in patients with FFR ≥0.75 [7]. The Fractional Flow Reserve versus 
Angiography for Multivessel Evaluation (FAME) study, published in 2009, found that 
revascularization only of ischemic lesions (i.e., those with FFR ≤0.80) was associated with 
28% fewer major adverse cardiac events compared with an angiography-guided strategy 
[8]. Furthermore, the FAME II study, published in 2012, showed FFR-guided PCI to also 
improve patient outcomes when compared with optimal medical therapy alone [9]. In fact, 
FFR is the only diagnostic method for guiding coronary intervention that has shown any 
benefit to patient outcomes to date. 
Figure 2: FFR measurement in vivo. Measurements must be acquired during maximal hyperemia to minimize 




To measure FFR clinically, a pressure wire is inserted percutaneously from the 
femoral or brachial artery, through the aorta, and into the coronaries where proximal and 
distal pressures are measured directly across multiple cardiac cycles. These values are then 
time-averaged and divided to acquire FFR, and a threshold of 0.8 is used to determine 
which patients should receive revascularization. Despite its proven efficacy, clinical data 
of attempted coronary interventions of intermediate stenoses have shown that FFR is used 
in only 6.1% of patients while 73.6% of patients were evaluated with angiography alone 
[10]. This underutilization can be attributed largely to the extra time and cost of the pressure 
wire, as well as the small but non-negotiable risk to the patient. Therefore, there have been 
considerable efforts in recent years to develop non-invasive alternative methods of 
determining FFR. 
1.3 Virtual Fractional Flow Reserve 
Virtual fractional flow reserve (vFFR) is a generic term for non-invasive 
alternatives to FFR wherein medical images are used to create patient-specific models of 
the coronary vasculature and computational fluid dynamics (CFD) is used to numerically 
solve the governing equations of fluid mechanics and estimate FFR. To compute vFFR, 
certain boundary conditions must be defined in the patient-specific model, including: the 
lateral wall geometry which describes the coronary luminal boundary; the inlet flow rate 
to simulate hyperemic coronary blood flow; and flow-splitting ratios at vessel branch 
points.  
1.3.1 Computed Tomography–Derived Fractional Flow Reserve 
The first example of vFFR was computed tomography (CT)–derived FFR (FFRCT), 




an anatomical model of the coronary arteries and a mathematical model of the coronary 
physiology to derive boundary conditions based solely on morphometric laws and 
volumetric CT data [11]. Because CT is unable to measure flow directly, total coronary 
flow is defined as a function of myocardial mass [12], flow-splitting between vessels is 
determined through Murray’s law [13], and lumped-parameter models are coupled to the 
aortic inlet, non-coronary vasculature, and coronary microcirculation [11]. 
In the Diagnosis of Ischemia-Causing Coronary Stenoses Obtained Via 
Noninvasive Fractional Flow Reserve (DISCOVER-FLOW) study, FFRCT was computed 
in 159 vessels from 103 patients undergoing CTA, invasive coronary angiography, and 
FFR measurement, and diagnostic performance of FFRCT was assessed in reference to 
invasive FFR. FFRCT and FFR were found to be well correlated (r = 0.717, p < 0.001) with 
a slight underestimation by FFRCT (0.022 ± 0.116, p = 0.016), and the area under the 
receiver-operator characteristics curve (AUC) was 0.90 (p = 0.001) [14].  
Though FFRCT allows for a non-invasive assessment of the functional significance 
of coronary stenosis, it does have several limitations inherent in CT. First, as mentioned 
previously, CT is unable to directly measure flow rate, requiring several assumptions to be 
made involving physio-morphic relationships and mean anthropometric data in order to 
estimate flow boundary conditions. Second, acquisition of CT volumetric data requires 
contrast injection and repeatedly exposing the patient to ionizing radiation. Third, CT is 
susceptible to blooming artifacts from calcium which can obstruct or artificially enlarge 




1.4 Coronary Flow Reserve 
A complimentary coronary physiologic measure to FFR is coronary flow reserve 
(CFR), which is defined as the ratio of hyperemic flow to basal flow [4]. In healthy 
individuals, CFR has been shown to be approximately 4.8, which indicates hyperemic flow 
is almost five times greater than basal flow [4, 15]. Unlike FFR, CFR is affected by both 
distal tissue bed vascular function and epicardial resistance, each of which can be assessed 
invasively by determining hyperemic microvascular resistance (HMR) and the hyperemic 
stenosis resistance (HSR), respectively [16]. For example, if the downstream small vessel 
vasodilation response is impaired, the HMR will increase and thereby reduce CFR. 
Similarly, to compensate for an increase in the HSR caused by CAD, the basal 
microvascular resistance (BMR) will decrease and reduce CFR, as the available coronary 
Figure 3: Illustration of Coronary Flow Reserve (CFR). (a) Coronary arterial blood flow travels through both 
epicardial vessels and microvasculature. Each can contribute to the total resistance. The resistance due to the 
epicardial vessels (blue) is the stenotic resistance (HSR), and the resistance due to the microvasculature 
(green) is the myocardial resistance (MR). (b) The flow (Q) can be modeled using a circuit analogy in which 
the total resistance is the sum of the HSR and MR. (c) Flow through the vessel varies between basal (𝑄⬚
𝐵 ) 
and hyperemic (𝑄⬚
𝐻 ) conditions due to changes in the MR, but it can be expressed as the ratio of the pressure 
change (ΔP) across the stenotic epicardial vessel to the HSR. FFR is the ratio of the pressure distal to the 
lesion during hyperemic flow (𝑃𝑑
𝐻) to the proximal pressure (𝑃𝑝
⬚), while CFR is the ratio of the hyperemic 






reserve is diminished [4]. Therefore, CFR and FFR are intrinsically connected, and an 
illustration of this interdependence can be seen in Figure 3. Because so many factors 
contribute toward patient-specific CFR, its value can vary substantially between patients. 
CFR can be measured clinically through magnetic resonance imaging (MRI) and positron 
emission tomography (PET) and can be estimated through single-proton emission 






CHAPTER 2.  TECHNICAL BACKGROUND 
2.1 Phase-Contrast Magnetic Resonance  
The phase 𝜑 of the magnetic resonance (MR) signal emitted from a spinning 
particle is determined as a function of the gyromagnetic ratio γ, the gradient strength over 
time G(t), the position of the particle over time r(t), and the duration of the gradient T as  




From this equation, it can be shown that a stationary spin exposed to a pair of 
bipolar gradients will experience no net phase shift, but a moving spin will experience a 
net phase shift proportional to the component of the velocity coincident with the direction 
of the gradient. By imaging a slice once with a pair of bipolar gradients and once without, 
the difference of the two images will be the phase shift created by the moving spins, thereby 
allowing in vivo quantification of flow velocities [17, 18]. This is referred to as phase-
contrast magnetic resonance (PCMR). Typically, only the through-plane velocity is 
measured so flow rate can be determined over cross-sectional area. It is possible to repeat 
or interleave PCMR measurements in three orthogonal directions to obtain the complete 
3D, time-resolved velocity field.  
2.2 Prospective Navigator Echo 
Navigator echoes are additional RF-pulses used to dynamically track anatomic 
motion during image acquisition. For example, to mitigate the effects of respiratory motion, 
a navigator is often used to track the motion of the diaphragm, and image data are only 




window (Figure 4). Though this does effectively compensate for respiratory motion, it 
greatly lowers scan efficiency as only a fraction of cardiac cycles fall within this acceptance 
window, and scans can be unpredictably long and require extensive planning to correctly 
implement. 
2.3 Self-Gating 
Self-gating is a novel concept for motion-compensation during MRI in which 
motion information is derived directly from the image data themselves [19]. In the 
implementation used in this project, data acquisition is performed using a three-
dimensional golden-angle radial k-space trajectory, beginning with a readout extending in 
a superior-inferior (SI) direction from the center of k-space [20]. Each SI line is then 
extracted and arranged temporally, and a one-dimensional Fourier transform is applied to 
create an SI projection of the image volume through which physiologic motion can be 
visualized (Figure 5).  
Figure 4: Prospective navigator-gating. (a) A one-dimensional beam is positioned over the right 
hemidiaphragm and is acquired prior to each potential image acquisition. (b) Edge detection determines if 




Self-gating relies on the same basic principle used in conventional prospective 
navigation: physiologic motion is tracked in a single dimension, and imaging is gated such 
that overall motion within the image data is minimized. Self-gating, however, has 
advantages over the conventional prospective approach due to it being a retrospective 
method. With prospective gating, imaging only occurs when the motion is within the 
acceptance window, and this window must be manually set prior to the start of the scan. If 
the subject’s breathing changes during the scan, several minutes can be wasted during 
which no data are collected. With retrospective gating, image data are acquired throughout 
the scan, and the motion-states are determined afterwards with consideration of the entire 
motion signal. This allows the total scan time to be much more predictable and requires 
less planning from the operator. There are several techniques which make use of the self-
gating principle to compensate for motion in cardiac imaging. Some of these are described 
in the sections below. A visualization of how these techniques relate to one another can be 
seen in Figure 6.  
Figure 5: Representative image of self-navigated data acquisition and motion extraction. Data is acquired 
using a 3D spiral phyllotaxis trajectory (left) starting with a line oriented in the superior-inferior (SI) 
direction. The SI lines from each acquisition are then concatenated temporally, and a 1D Fourier transform 




2.3.1 Self-Navigated, Motion-Corrected Coronary MRA 
Self-gating principles have been applied to cardiac and coronary imaging [21-24]. 
In its first iteration, prospective electrocardiogram (ECG)–gating was employed such that 
image data were only acquired during a single cardiac phase, typically end-systole or mid 
to late–diastole [21]. The bright-blood acquisition allows for the left ventricular (LV) blood 
pool to be tracked through self-navigation, and principal component analysis can then be 
used to extract the respiratory motion signal from the acquired data. Through the Fourier 
shift theorem, a translation in the image domain equates to a phase-shift in the frequency 
domain. Therefore, the acquired data are phase-shifted corresponding to their respective 
amount of respiratory displacement, followed by regridding and reconstruction of the final 
image volume. This allows for a free-breathing, whole-heart image acquisition which is 
prospectively cardiac-gated and retrospectively corrected for respiratory motion, thereby 
creating a fully motion-compensated image set. 





A novel reconstruction framework called extradimensional golden-angle radial 
sparse parallel (XD-GRASP) MRI was recently proposed in 2016 [25]. Through it, image 
data are artificially undersampled by binning them into additional dimensions 
corresponding to different motion states, and compressed sensing techniques are then used 
to reconstruct the undersampled data.  
2.3.3 4D-GRASP Coronary MRA 
The principles of self-navigation MRA can be combined with XD-GRASP to create 
motion-resolved images of the coronary arteries [24]. If prospectively cardiac-gated raw 
image data and the respiratory motion signal are acquired through the methodology 
described in section 2.3.1, the acquired data can then be binned according to the respective 
respiratory position, thereby creating a fourth dimension (4D-GRASP). This will group 
data sets such that all sets acquired at end-inspiration are together, all sets acquired at end-
Figure 7: Representative image of 4D-GRASP binning. Respiratory motion is extracted from the image data, 




expiration are together, etc. (Figure 7). Once compressed-sensing reconstruction is 
completed, the resulting image set will be across four dimensions: three spatial and one 
respiratory. Within each bin, respiratory motion will be minimized, so no motion-
correction is necessary prior to reconstruction. This method uses prospective cardiac gating 
so all respiratory motion states will be at a single cardiac phase. 
2.3.4 5D-GRASP Coronary MRA 
Another implementation of XD-GRASP is to bin datasets into both respiratory and 
cardiac dimensions, thereby allowing for five total dimensions (5D-GRASP) [26]. In the 
free-running framework (FRF) presented by Di Sopra et al. in 2019, image data are 
acquired continuously without any prospective gating or ECG-triggering [27]. This allows 
for collection of data throughout the subject’s respiratory and cardiac cycles. The cardiac 
and respiratory cycles oscillate at different frequencies, allowing for the two physiologic 
Figure 8: Representative image of 5D-GRASP binning. Data are acquired rapidly without gating, and the 
total motion is extracted from image data. Relative frequencies are used to separate respiratory and cardiac 





signals to be separated, and data are then binned into a two-dimensional array of three-
dimensional data sets (Figure 8). 5D-GRASP allows 3-dimensional reconstructed images 
of the heart at different temporal locations, providing new or potentially more accurate 
diagnoses to be performed. Furthermore, because the data are no longer prospectively 
binned, then the acquisition should be less sensitive to variations in the heart-rate during 




CHAPTER 3.  HYPOTHESIS AND SPECIFIC AIMS 
3.1 Summary of Background 
Revascularization for CAD using PCI has been shown to only benefit patients for 
whom the atherosclerotic plaques create a functionally significant stenosis, and FFR is the 
current gold-standard for making this determination. Despite its proven efficacy, FFR is 
underutilized due to its invasive and expensive nature. vFFR is a group of techniques that 
seek to develop non-invasive alternatives to FFR through patient-specific CFD modeling. 
The most notable example of vFFR is FFRCT, which uses CT image data to directly 
characterize vessel morphology and indirectly estimate hyperemic flow. Hyperemic flow 
is necessary to accurately measure FFR as it enforces the condition of minimized 
downstream resistance.  However, CT cannot quantify patient-specific CFR which defines 
this hyperemic behavior. MRI can directly measure flow velocities and determine in vivo 
through PCMR. Self-gating principles allow for physiologic motion to be measured from 
MR image data, which can then allow for either motion-correction or XD-GRASP and 
binning techniques to reconstruct a fully motion-resolved image set. Therefore, MRI 
appears specifically well-suited for vFFR calculation due to its ability to quantify both the 
patient-specific anatomy and flow.  
3.2 Central Hypothesis 
We hypothesized that MRI could acquire both the geometric and flow boundary 





Flow information can be quantified directly in vivo using PCMR, but its use in 
quantifying inlet flow boundary conditions for coronary arterial CFD simulations has not 
been sufficiently validated. Different implementations of vFFR—specifically FFRCT—
have made assumptions concerning what patient-specific flow information is necessary for 
the simulations, and these assumptions have also not been well validated. Therefore, we 
first determined what patient-specific flow information was necessary for accurate vFFR 
calculation, which was done through error assessment of vFFR calculated using different 
assumptions of hyperemic coronary flow. Then, flow through the coronary arteries was 
measured with PCMR in a set of volunteers and evaluated for consistency and repeatability 
with regards to the patient-specific flow information necessary for inflow boundary 
conditions.  
Characterizing the coronary arterial luminal geometry through MRI had been 
shown to be possible [28], but it is often unreliable with prospective ECG and respiratory 
gating. Self-gating offers a novel technique for motion-compensation through retrospective 
gating and motion-correction, which could more consistently provide images suitable for 
coronary geometric characterization. Self-gating lends itself to multiple implementations 
for MRA. However, due to the complexity of implementation and recent appearance of the 
techniques, they have not been fully assessed for coronary imaging. Therefore, multiple 
techniques were applied to a cohort of patients undergoing clinically indicated cardiac 




3.4 Aim 1: Determine If PCMR Can Provide the Inlet Flow Boundary 
Conditions Necessary for Calculation of vFFR Through CFD 
3.4.1 Aim 1a: Determine What Inlet Flow Boundary Conditions Are Necessary for 
Calculation of vFFR through CFD 
Clinical FFR is measured during maximal hyperemia, meaning that CFD should 
use the patient-specific hyperemic waveform as the inlet flow boundary condition to most 
accurately simulate flow through the coronary artery. However, because most imaging 
modalities cannot directly quantify flow, assumptions have been made in different 
implementations of vFFR. For example, FFRCT uses the myocardial mass to estimate the 
time-average basal flow, then uses population-averages to predict the waveform and 
microvascular response to hyperemia. We hypothesized that vFFR calculation is insensitive 
to the time-dependence of the flow waveform but requires patient-specific CFR. We tested 
this through a series of CFD simulations comparing hyperemic, basal, and steady 
waveforms. 
3.4.2 Aim 1b: Investigate if PCMR Can Be Used to Acquire the Inlet Flow 
Boundary Conditions for Calculation of vFFR 
Aim 1a determined what patient-specific flow information was needed to calculate 
vFFR, and subsequently PCMR was investigated for its ability to quantify this information 
in vivo. PCMR was applied to measure flow through the left main artery, right coronary 
artery, and coronary sinus in a series of volunteers. Since we cannot know the true flow in 
human coronaries, measurements were analyzed for repeatability. Two hypotheses were 




consistency, and 2) the combined measurements of coronary arterial flows within a specific 
patient will show agreement with coronary sinus flow measurements. 
3.5 Aim 2: Determine if Self-Gated MRI Can Provide Image Quality 
Sufficient for Coronary Geometry Characterization 
3.5.1 Aim 2a: Determine If Self-Navigation MRA Can Provide Image Quality 
Sufficient for Coronary Geometric Characterization 
The self-navigation MRA protocol described in section 2.3.1—whereby images are 
acquired during prospective cardiac-gating, followed by retrospective correction to 
compensate for respiratory motion—was applied to a cohort of patients undergoing 
clinically indicated cardiac MRI. Images were acquired and image quality was assessed. It 
was hypothesized that the retrospective respiratory motion–compensation technique used 
by self-navigation MRA could consistently provide full coronary geometric 
characterization. 
3.5.2 Aim 2b: Determine If 4D-GRASP MRA Can Provide Image Quality Sufficient 
for Coronary Geometric Characterization 
The 4D-GRASP protocol described in section 2.3.3—whereby images are acquired 
during prospective cardiac gating, followed by binning according to respiratory state and 
reconstruction using compressed sensing techniques—was applied to a cohort of patients 
undergoing clinically indicated cardiac MRI. The raw data were also reconstructed using 
motion-corrected, self-navigation MRI. It was hypothesized that the 4D-GRASP images 




3.5.3 Aim 2c: Determine If 5D-GRASP MRA Can Provide Image Quality Sufficient 
for Coronary Geometric Characterization 
The 5D-GRASP protocol described in section 2.3.4—whereby images are acquired 
during a free-running, continuous acquisition, followed by binning according to both 
respiratory and cardiac state and reconstruction using compressed sensing techniques—
was applied to a cohort of patients undergoing clinically indicated cardiac MRI as well as 
a cohort of pigs. Three separate acquisitions were investigated, including a non-contrast 
acquisition, a gadolinium-enhanced acquisition, and a ferumoxytol-enhanced acquisition. 
Images were acquired and assessed for their ability to characterize the coronary geometry. 
It was hypothesized that the ferumoxytol-enhanced images would perform better than the 
other two 5D-GRASP techniques, the 4D-GRASP technique, or self-navigation MRI.  
3.6 Outcomes 
The first outcome of Aim 1 was a quantitative determination of what flow 
information is needed to calculate vFFR through CFD. Through this, the limitations on 
which imaging modalities may or may not be used for vFFR could be more objectively 
ascertained. This information was then used in the second half of Aim 1 to validate whether 
or not PCMR could acquire the requisite flow data. The primary outcome of Aim 2 was to 
investigate implementations of self-gated acquisition and reconstruction frameworks and 
quantify their capacity for three-dimensional coronary MRA. Each sub-aim was designed 
to test a specific implementation and determine if it could be used in calculating vFFR. 
When an approach did not succeed in this objective, we investigated what was the likely 
cause of failure and proposed the next implementation to test which should improve upon 




3.7 Significance and Innovation 
CAD is the leading cause of death globally, and trends indicate that in the United 
States half of all healthy 40-year-old men and one in three healthy 40-year-old women will 
develop it in their lifetimes [29]. Currently, the only method proven to improve patient 
outcomes and survivability following revascularization for stable CAD is invasive FFR 
measurement. Despite its proven efficacy, it remains underutilized due to its associated 
costs and risks. A non-invasive alternative to FFR could allow clinicians to accurately 
assess the functional severity of coronary stenoses without requiring catheterization of the 
patient.  
Early efforts to develop vFFR have focused on using CT due to its proficiency in 
imaging coronary arterial geometry. Despite excitement within the diagnostic and invasive 
cardiology community for FFRCT, there are significant drawbacks for CT-based FFR. CT 
is not able to directly measure flow, which is a primary determinant of the pressure 
differential across the stenosis. Basal flow can be approximated from morphologic data 
and allometric scaling, but CT also cannot characterize the downstream myocardial tissue 
which determines distal resistance and contributes towards the patient-specific CFR. CT 
also suffers from beam-hardening artifacts which can cause an overestimation in the degree 
of stenosis or make the vessel geometry difficult or impossible to determine. Lastly, CT 
delivers a non-trivial dose of radiation for a diagnostic test, which poses a concern for its 
clinical use. The issues presented by the presence of calcium as well as the lack of patient-
specific flow and CFR measurements have led to serious questions about the accuracy of 
FFRCT. The overall per-vessel diagnostic accuracy of FFRCT has been shown to be 




below 0.53 or above 0.93. In fact, for FFRCT values between 0.70 and 0.80, the diagnostic 
accuracy fell as low as 46% [30]. This indicates that FFRCT struggles primarily in 
accurately diagnosing patients with moderate ischemia, which are precisely the cases for 
whom accuracy is the most critical. 
MRI, however, appears to have several advantages over CT in calculating vFFR. 
MRI does not use ionizing radiation, which could increase patient compliance and also 
enable use of vFFR in longitudinal studies or as an endpoint in treatment studies. 
Importantly from a fluid dynamics standpoint, MRI is able to determine flow velocity using 
the phase-contrast technique. This measurement can provide patient-specific input flow 
boundary conditions to the CFD model. Furthermore, PCMR can quantify the hyperemic 
behavior necessary to measure vFFR. It is known that CTA has a higher resolution than 
MRA for imaging the coronary arteries. However, the presence of calcium often mitigates 
these resolution advantages as the beam-hardening artifacts obfuscate the true stenosis 
geometry. Because calcium lacks mobile protons, however, these artifacts do not plague 
MRI as they do CT.  
The first aim seeks to investigate a) what patient-specific flow information is 
necessary to calculate vFFR, and b) if PCMR is capable of acquiring this information. If it 
is seen that patient-specific hyperemic flow information is necessary to accurately quantify 
vFFR, then this would indicate that CT will always suffer from errors in quantifying vFFR 
due to its inability to quantify patient-specific CFR. Furthermore, while the ability of 
PCMR to quantify in vivo arterial flow has been proven previously, its specific application 





The second aim investigates if self-gated MRI can sufficiently characterize 
coronary anatomic geometry for vFFR calculation. Self-gating is a novel technique with 
multiple implementations which show promise for applications where physiologic motion 
is present. These aims will attempt to investigate these implementations in coronary 
imaging of patients which have not yet been adequately studied.  
The major innovation in this proposal is development of techniques that would 
enable a new, non-invasive method of determining vFFR with MRI. Having physiology-
based coronary measurements in patients is critical for optimal patient management, but 
obtaining these measurements in the catheterization lab is time-consuming, expensive, and 
impractical on a routine basis. The ability to determine coronary physiology metrics non-
invasively and without employing ionizing radiation would be a paradigm shift in guiding 
coronary intervention. The non-invasive nature of the test would allow FFR to be used to 
assess patient populations that could most benefit from PCI and also allow FFR to be used 
in trials to assess novel treatment therapies.   
Multiple trials have shown the advantages of FFR-guided PCI for improving patient 
outcomes and for eliminating unneeded and expensive PCI procedures. However, due to 
cost, complexity, and reimbursement issues, FFR is not often employed in the 
catheterization lab. The development of an accurate, reproducible method of non-
invasively determining FFR would dramatically increase its clinical use as the current 
barriers would be reduced. This would result in significant cost savings to the healthcare 
system by reducing the number of unnecessary catheterization procedures thus deploying 




PCI requires high utilization of resources and use of individuals with a high level 
of clinical expertise. It is imperative to utilize these resources in a way that is most effective 
in improving and extending patients’ lives. PCI guided by FFR yields improved patient 
outcomes for major adverse cardiac events compared to angiography-guided PCI. By 
removing the barriers of requiring an invasive test, we can dramatically increase the use of 
FFR, positively impact patient care, and improve allocation of cardiology resources to 





CHAPTER 4.  DETERMINATION OF FLOW 
CONDITIONS NECESSARY TO 
CALCULATE VFFR 
4.1 Introduction 
To calculate vFFR through CFD, inlet flow boundary conditions must first be 
defined using a combination of patient-specific information and simplifying assumptions. 
For example, for FFRCT, the subject is first imaged through CT which exclusively provides 
anatomic characterization. The total myocardial mass of the individual is estimated from 
the CT image data, which allows for an estimation of the patient-specific basal coronary 
arterial flow—that is, the flow through the coronary arteries when the subject is at rest—
through allometric scaling [11]. The rationale behind this is that the rate of myocardial 
blood flow should be proportionate to the amount of myocardial tissue, and the ability to 
predict one with the other has been validated previously [12]. This relationship, however, 
only applies to basal coronary flow, while FFR is defined only during hyperemic—or 
stress—flow conditions. 
To account for this, FFRCT artificially scales the predicted basal flow by an 
estimated CFR value, which is done through modification of resistances in the overall 
lumped-parameter model. The epicardial resistance is automatically adjusted through the 
presence of a stenosis, but CFR is determined by both the epicardial and microvascular 
responses to stress, and CT has no means through which it can estimate patient-specific 
microvascular resistance. Therefore, the microvascular resistance is scaled by a factor of 





This assumption has not been validated or thoroughly investigated; however, it 
seems likely that it would weaken the predictive power of the technique. Because FFR is a 
measure of the pressure drop across the stenotic lesion and pressure gradient is directly 
related to the flow rate via Ohm’s Law, it follows that any linear change in the inlet flow 
would likely result in a proportionate change in the calculated FFR. Therefore, it is 
hypothesized that basal flow scaled by patient-nonspecific CFR cannot accurately 
calculate vFFR.  
 Flow through the coronary arteries is naturally pulsatile, but hyperemia does not 
scale the flow waveform uniformly across the cardiac cycle, so scaling the basal flow by 
the patient-specific CFR will not produce the hyperemic flow waveform (Figure 9). 
Because of this, even if the patient-specific CFR is known, the simulated hyperemic flow 
would not be representative of the true hyperemic flow pattern. However, clinical FFR is 
Figure 9: Representative flow waveform comparison for one patient. Both the basal and hyperemic flows 
were acquired using Doppler wire, and the basal flow was then scaled by a range of CFR values. When the 
basal flow is scaled by the patient-specific CFR—2.8—, the time-average flow rate is the same for both it 
and the hyperemic flow. Scaling the basal flow by the cohort-average CFR—2.2—produces the same basal 




defined using the time-averaged pressure measurements, which, in theory, should not 
depend on the flow waveform used. Therefore, it is hypothesized that scaling the basal 
flow by the patient-specific CFR should allow for an accurate calculation of vFFR. In fact, 
by the same logic, time-dependent behavior should not influence the calculation of vFFR, 
meaning steady state flow simulations should provide the same estimation of vFFR as 
pulsatile simulations with the same time-averaged flow.  
The purpose of this study is, therefore, to investigate the effect of varying CFR 
values on the accuracy of vFFR predicted from CFD. Specifically, we will use a coronary 
geometry determined by MRA coupled with basal and hyperemic coronary flow values 
measured by intra-coronary Doppler in a patient cohort undergoing physiologic evaluation 
of flow-limiting lesions in the catheterization lab. This allows for comparison of vFFR 
predictions using a clinically representative range of CFR values derived from patient-
specific basal and hyperemic flow waveforms.  
4.2 Methods 
An overview of the experimental approach is presented below, followed by a 
detailed explanation of each component of the methodology. First, a coronary arterial 
computational model was constructed using MRA image data acquired from a single 
patient presenting with moderate CAD. Second, resting and hyperemic flows through the 
coronary arteries were measured in a separate cohort of patients (n=9) undergoing 
clinically indicated intracoronary Doppler ultrasound. Third, CFD was used to determine 
vFFR values with various applied hyperemic flow conditions, including: i) in vivo 
hyperemic flow by intra coronary Doppler (true vFFR), ii) basal flow scaled by the 




average CFR estimates (population-scaled vFFR). The scaled vFFR values were 
predicted under both steady and transient flow conditions. These scaled vFFR values were 
compared with the true vFFR values to assess accuracy, correlation, and concordance, 
thereby evaluating how changing the hyperemic flow response—as measured by CFR—as 
well as time-dependent flow patterns affect vFFR prediction with a constant geometry. A 
graphical flowchart of these methods can be seen in Figure 10. The study was approved by 
the Institutional Review Board (IRB), and written informed consent was obtained from all 
subjects prior to either magnetic resonance scanning or intracoronary Doppler 
measurement.  
Figure 10: Overview of Aim 1a Experimental Design. A single left coronary artery tree was acquired from 
an MRI of a patient with a 50% stenosis in the LAD. Hyperemic and basal flow waveforms were measured 
in patients (n=9) with mild CAD using intracoronary Doppler. Each hyperemic flow waveform was applied 
as an inflow boundary conditions for the anatomic model to determine the true vFFR value via CFD. Each 
basal flow waveform was then scaled by either a patient-specific or estimated CFR value to approximate the 
hyperemic flow. These scaled flow rates were then applied as inflow boundary conditions to both steady and 
transient CFD simulations to estimate vFFR—i.e., CFR-scaled vFFR. These CFR-scaled vFFR values were 




4.2.1 Coronary Anatomy Model Geometry 
A patient presenting with NYHA class III ischemic heart failure was imaged prior 
to cardiac resynchronization therapy as part of an IRB-approved study [31]. Imaging was 
performed on a 3 T MRI scanner (MAGNETOM Trio, Siemens Healthcare) using a six-
element phased-array cardiac coil. A 3D, whole-heart, navigator- and ECG-gated 
inversion-recovery FLASH sequence with a centric k-space trajectory acquired coronary 
images in the transverse plane at a resolution of 0.64 x 0.64 x 0.75 mm3. Images were 
acquired in diastole during the slow infusion of a gadolinium-based contrast agent [32]. 
The left main (LM), left anterior descending (LAD), and left circumflex (LCX) arteries 
were segmented from the image data using a Frangi vessel enhancing post-processing filter 
followed by a colliding fronts segmentation algorithm (Vascular Modeling Toolkit) [33-
35]. The resulting triangulated surface geometry was imported into Geomagic (Geomagic, 
Inc.) to generate a smooth 3D surface. This surface was imported into ICEM meshing 
software (ANSYS, Inc.) to generate the 3D computational mesh. The model was generated 
with approximately 100,000 tetrahedral elements and 150,000 six-node pentahedral 
elements comprising eight boundary layers with a linear growth factor of 1.1 such that each 
innermost element was the same volume as the adjacent tetrahedral element. Flow 
extensions were added to the inlet and each outlet by projecting the edge contour in line 
with the local trajectory of the boundary surface (Figure 10).  
4.2.2 Coronary Flow Measurements 
Intracoronary Doppler flow measurements were acquired in the LAD of patients 
(n=9) with mild CAD that participated in a previous IRB-approved study described 




the coronary artery, and a 0.014-in pressure and Doppler flow velocity monitoring 
guidewire (ComboWire, Volcano Corp) was advanced through the catheter into the 
proximal, non-tortuous portion of the vessel to measure the inlet basal (resting) velocity. 
Subsequently, 140 µg ∙ kg-1 ∙ min-1 intravenous adenosine was infused for 3 minutes to 
induce maximal coronary hyperemia, allowing for hyperemic velocity measurement.  
4.2.3 Hyperemic Flow Conditions for CFD Simulations 
Various hyperemic flow conditions were applied to evaluate their effects on 
computed vFFR values. The first condition was the pulsatile hyperemic flow measured in 
vivo for each patient, which was used to define the true vFFR against which the other 
predicted vFFR values would be compared.  
Next, the patient-specific CFR value was calculated by taking the ratio of time-
averaged, Doppler-wire measured hyperemic-to-basal flow rates across the cardiac cycle. 
For each patient, the measured basal flow was scaled by the patient-specific CFR value to 
give a flow waveform with the same time-averaged flow rate as the measured hyperemic 
flow (Figure 9). This flow was used to compute the patient-scaled vFFR.  
For each patient, the basal flow rate was also scaled by a series of global CFR 
estimates which were not specific to the patient. A total of ten global CFR values were 
used, including nine values ranging from 1.0 to 5.0 by increments of 0.5 and a tenth value 
representing the average CFR across the patient cohort. These values were chosen to 
represent the scope of physiologically relevant CFR values in patients presenting with 
CAD. These flows were used to compute a series of population-scaled vFFR values for 
each patient. The specific population-scaled vFFR found using the cohort-average CFR 




4.2.4 CFD and FFR Calculation 
CFD simulations were run using Fluent (ANSYS, Inc.). While the true vFFR was 
computed only under transient flow conditions, the patient-scaled vFFR and population-
scaled vFFR values were computed using both transient and steady conditions. For each of 
the nine patients on whom intracoronary flow measurements were obtained, 23 vFFR 
values were computed: the true vFFR found under transient flow, the patient-scaled vFFR 
found under both transient and steady flow, and the 10 population-scaled vFFR values 
found under both transient and steady flow.  
For each case, the simulated hyperemic flow rate was prescribed as a blunt inlet 
flow boundary condition, inlet pressure was set at 100 mmHg, and outlet flow-splitting 
conditions were determined using Murray’s law [13]. For the transient flow cases, the 
solution was computed across three cardiac cycles comprising 300 time steps, each at a 
heart rate of 60 beats per minute. Blood was modeled as Newtonian with a density of 1060 
kg ∙ m-3 and dynamic viscosity of 0.0035 Pa ∙ s. We used the SIMPLE algorithm for 
pressure-velocity coupling and second-order Green-Gauss node-based discretization for 
momentum and pressure. For each time step, convergence was achieved once the residuals 
of momentum and continuity fell below 10-5. The computed pressure was then sampled 
along the centerline of the vessel and divided by the inlet pressure to calculate vFFR along 
the length of the vessel, in accordance with clinical practice. The clinically relevant vFFR 
value—found 4 mm distal to the region of minimal lumen area —was then recorded as the 
true vFFR. In the transient cases, the computed vFFR values were time-averaged to 




4.2.5 Statistical Analysis 
Continuous data are reported as mean ± standard deviation. Across all scaled CFR 
values, the difference between the true vFFR value and scaled vFFR was calculated. The 
error from each CFR group was evaluated by a Fisher-Pitman permutation test for matched-
pairs at a significance level of 0.1. Correlation between scaled vFFR and true vFFR values 
for each patient was evaluated by calculating the Pearson correlation coefficient and the 
Spearman’s rank correlation coefficient at a significance level of 0.001. Lastly, 
concordance was evaluated through a Bland–Altman analysis and calculation of Lin’s 
concordance correlation coefficient [38, 39]. 
4.3 Results 
4.3.1 Transient CFD Results 
The CFR values for the cohort ranged from 1.45 to 2.87 with a mean value of 2.18 
± 0.55. The difference between the various scaled vFFR values and the true vFFR (vFFR 
a b 
Figure 11: Results from transient CFD simulations for error in predicting true vFFR using different simulated 
hyperemic flow conditions. (a) Error of patient-scaled and cohort-scaled vFFR in predicting true vFFR. (b) 




error) was determined across all 9 patients. Paired comparison of the patient-specific vFFR 
with the true vFFR produced the lowest mean error and standard deviation (-0.02 ± 0.03, 
p > 0.1) of the groups tested (Figure 11a). The cohort-scaled vFFR did not show significant 
differences with true vFFR (-0.08 ± 0.15), but its paired difference did show a much wider 
standard deviation than was seen with patient-specific vFFR (Figure 11a). The population-
scaled vFFR values for global CFR ranging from 1.0 to 5.0 displayed significant error for 
nearly all values (Figure 11b). For example, using a CFR of 1.0—i.e., the unscaled basal 
flow—resulted in a mean difference of 0.15 ± 0.09; using a CFR of 4.8—the average value 
for the healthy population—gave a difference as large as -0.66 ± 0.64 [4, 15]. Aside from 
the cohort-scaled vFFR, the only other population-scaled vFFR which did not exhibit 
significant difference with true vFFR was the group tested with global CFR of 2.0 (-0.03 
± 0.11) which can likely be attributed to it being so close to the cohort-average CFR of 
2.18.  
The patient-scaled vFFR also showed the greatest bivariate correlation (r2 = 0.98, 
p < 0.001), rank correlation (ρ = 0.93, p < 0.001), and concordance (ρc = 0.98) with true 
a b c 
Figure 12: Correlation and concordance of true vFFR and scaled vFFR. (a) Correlation between true vFFR 
and scaled vFFR from transient CFD simulations. (b, c) Bland-Altman plots evaluating concordance of true 




vFFR of the groups tested (Figure 12a,b). Though cohort-scaled vFFR showed 
nonsignificant mean error, it does not show a high predictive power for true vFFR (r2 = 
0.76; ρ = 0.8; ρc = 0.69) (Figure 12a,c). Interestingly, the bivariate correlation for the 
population-scaled vFFR values estimating true vFFR were only seen to fall between 0.75 
and 0.79, and the rank correlation was found to be 0.8 for every group. Unlike the 
correlation, the concordance with true vFFR was seen to vary for the population-scaled 
vFFR groups, with CFR of 2.0 showing the best agreement (ρc = 0.79) and CFR of 5.0 
showing the worst (ρc = 0.10). 
4.3.2 Steady-State CFD Results 
Similar results were seen from the steady vFFR predictions. The patient-specific 
CFR again showed the lowest mean error and variance (0.00 ± 0.01, p > 0.1) and the 
greatest predictive power (r2 > 0.99; ρ > 0.99; ρc > 0.99). CFR of 2.2—the patient 




average—and 2.0 were the only nonspecific CFR values which produced nonsignificant 
error, but all nonspecific groups showed only moderate predictive power (0.74 < r2 < 0.76; 
ρ = 0.8; 0.1 < ρc < 0.8). Direct comparison of the vFFR values predicted from steady 
simulations with those predicted from the transient simulations show a very strong 
predictive power (r2 = 0.9994) (Figure 13). 
4.4 Discussion 
The major findings of this study are: 1) scaling the basal coronary flow waveform 
by the patient-specific CFR yields equivalent vFFR results to using the actual measured 
hyperemic flow waveform, 2) using a population average CFR for scaling will on average 
yield accurate vFFR results but will not provide predictive results for individuals whose 
CFR deviates from the average, 3) steady-state CFD estimates of vFFR are equivalent to 
transient CFD estimates for a given CFR value.  
Myocardial ischemia can result from epicardial disease, microvascular disease, or 
a combination of both. Clinical indication for intervention on epicardial stenosis has been 
shown to be most successful when guided by the FFR, which approximates the reduction 
in flow through a given vessel due to an anatomic narrowing. Accurate measurement of 
this flow reduction relies on the assumption of maximal hyperemia, in which the 
downstream microvascular resistance is minimized. The physiologic response to 
hyperemia is, however, patient-specific, and depends on both the stenotic resistance 
contributed by the epicardial vessels and the downstream hyperemic microvascular 
resistance. Though it is possible to estimate the value of HSR through anatomic 
measurements and allometric scaling, HMR can only be measured through direct 




coronary disease is not uncommon, the presence or severity of one cannot be used as a 
direct indicator of the presence or severity of the other. In 2017 it was shown that as few 
as 68% of patients with moderate coronary stenosis had concordant FFR and CFR findings 
[16].   
vFFR is an emerging methodology that seeks to provide a non-invasive alternative 
to invasive catheter-based FFR. Arguably the most well-known of these approaches is 
FFRCT [11]. As CT is incapable of quantifying the CFR or HMR, its flow boundary 
conditions rely on population-average physiologic responses to hyperemia. Though results 
of this methodology for vFFR have shown some success in predicting invasive FFR, the 
correlation between the two measurements does not indicate strong correlation (r2=0.54), 
and its diagnostic accuracy has shown to suffer substantially when predicting FFR values 
near the clinical cutoff (0.80) where specificity is most needed by clinicians [30]. It is 
possible that these limitations in efficacy are due at least in part to the assumptions made 
regarding HMR and, by extension, CFR.  
Scaling the basal flow waveform by the time-averaged, patient-specific CFR does 
not replicate the exact hyperemic time-dependent flow waveform for a given patient. This 
is due to the interactions between the myocardium and the microvasculature, resulting in 
phasic fluctuations of the intracoronary resistance [40]. Since the intracoronary resistance 
is not uniform across the cardiac cycle during resting flow, it has varying levels of response 
to hyperemic induction as well, resulting in a time-dependent CFR, which can be seen in 
Figure 9. However, because FFR is calculated as the time-averaged ratio of distal and 
proximal pressure in the coronary, it is effectively insensitive to temporal fluctuations and 




predicted with either the hyperemic flow waveform or the basal waveform scaled by the 
patient-specific CFR was found to be nearly identical. This means that to define the 
boundary conditions necessary for computing vFFR, inlet coronary flow during hyperemia 
does not need to be obtained directly and can instead be approximated using basal coronary 
flow measurements and patient-specific CFR.  
Because we found that vFFR would be insensitive to temporal fluctuations, it 
follows that running steady-state simulations using the time-averaged hyperemic flow 
would similarly provide accurate predictions of hyperemic vFFR. In fact, vFFR calculated 
with the time-averaged hyperemic flow rate was seen to predict hyperemic vFFR with the 
same accuracy as the transient CFD simulations. These results agree with those published 
by Morris et al. in 2017 who developed a “psuedotransient” methodology to calculate time-
dependent vFFR values driven by values calculated from a steady CFD solution[41]. Their 
psuedotransient vFFR values showed strong correlation with the fully transient vFFR 
because the time-average results show negligible difference. Because the time-average 
FFR value is used as the primary indicator for clinical guidance, this supports that a steady-
state analysis is sufficient. The implications of this are twofold. First, computation time for 
steady conditions is significantly lower than for unsteady conditions, allowing for 
utilization of stricter convergence criteria and for results to be returned much more quickly 
to the clinician. Second, it means that only the time-averaged basal coronary flow and CFR 
are needed to fully define the inflow boundary condition, and this information may be 
significantly easier to obtain in vivo. 
Though the calculation of vFFR appears to be time-insensitive, it is still sensitive 




non-patient-specific CFR values near the population average produced vFFR values that 
were, on average, not significantly different from hyperemic vFFR, but deviations from the 
population average resulted in increasingly large deviations in estimating vFFR. Predictive 
power of CFR-scaled vFFR for hyperemic vFFR was never strong for any estimated CFR 
value, and correlation was independent of the estimated CFR as well. This indicates that 
patient-specific characterization of the hyperemic flow rate needs to be used to accurately 
predict vFFR. Therefore, the choice in imaging modalities is limited to those that can 
measure both anatomy and flow. One could use a combination of imaging modalities to 
accomplish this, such as using both CT—to acquire the coronary anatomy and estimate the 
basal coronary flow rate through allometric scaling as described by Choy and Kassab 
[12]—and positron emission tomography (PET)—to assess the patient-specific CFR and 
determine the hyperemic response [42]. Perhaps a more feasible clinical solution would be 
to use MRI which can acquire both the anatomy and flow directly.  
There are limitations to this study. All comparisons were made between vFFR 
values without comparison with true, invasive FFR. Though the intracoronary Doppler 
used to measure the flow also acquired the necessary pressure information to obtain 
invasive FFR, a direct comparison between the vFFR and FFR would not have been 
appropriate due to the fact that we used a single patient geometry from a subject where 
flow was not measured. The geometry was kept constant throughout all simulations to 
remove it as a variable and focus on how the model was sensitive to the inflow boundary 
condition, but this resulted in an inability to directly validate these measurements against 





This study found that using patient-specific CFR to scale the basal flow waveform 
can accurately predict the vFFR calculated with the hyperemic flow, while using patient-
nonspecific CFR to scale the basal waveform cannot accurately predict vFFR for individual 
patients. It was also found that steady simulations can predict vFFR accurately compared 
with unsteady simulations. These results are important for future work in quantifying vFFR 
in patient studies. The necessity for having patient-specific hyperemic flow behavior means 
that assumptions about CFR cannot be used to scale the patient’s basal flow prior to its use 
as a boundary condition without significantly sacrificing the model’s predictive power. The 
results also show that it would only be necessary to acquire the time-average basal flow 
rate and the patient-specific CFR, which could prove to be significantly easier than directly 




CHAPTER 5.  INVESTIGATION OF CORONARY PCMR 
5.1 Introduction 
Nuclear magnetic resonance stems from Larmor’s equation which relates the 
angular momentum of a particle to its gyromagnetic ratio and the strength of an externally 
applied magnetic field [43]. Spatially varying the magnetic field causes protons at different 
locations to spin at different speeds, thereby encoding spatial information into recorded 
signals and allowing for MRI. When spinning protons are exposed to a bipolar magnetic 
gradient—two gradients of equal magnitude but opposite direction—a phase shift is 
encoded into the spins. For stationary particles, the phase shift induced by the first half of 
the gradient is undone by the second half. However, for a moving particle, the phase shifts 
induced by each half of the gradient will not be equal in magnitude as the applied magnetic 
field will vary with the particle’s location. Therefore, a net phase shift will be created in 
the particle, proportionate to the particle’s average velocity over the duration of the applied 
bipolar gradient. This is the underlying principle which allows for PCMR to directly 
quantify velocity in vivo [17, 18, 44].  
In clinical cardiac scans, the most common implementation of PCMR is single 
slice, time-resolved one-dimensional velocity-encoding phase-contrast MRI (2D PCMR), 
which is typically acquired during a breath-hold. Data are acquired in one plane of interest 
with velocity encoded into a single direction. For quantifying arterial blood flow, this plane 
would be positioned normal to the vessel with velocity encoded in the through-plane 




motion from the image, and ECG-gating is used to correctly align the acquired data into 
their discretized time phases across the cardiac cycle.  
Navigator-gating can be employed to allow for a free-breathing approach. As 
described in section 2.2, the navigator records the position of the diaphragm, and imaging 
is prospectively-gated to only occur when it is in a user-defined position. For whole-heart 
imaging, this can be very problematic due to the quantity of data needed for the acquisition, 
but PCMR requires much less data which makes navigator-gating a viable option for 
respiratory motion compensation. Time-resolved, three-dimensional phase-contrast MRI 
(4D PCMR) is a novel application of navigator-gated PCMR in which velocities are 
measured across time in three orthogonal velocity encoding directions [45].  
In Chapter 3, it was concluded that to accurately calculate vFFR, patient-specific 
hyperemic flow information is necessary in addition to the patient-specific geometry. MRI 
becomes an obvious candidate as the imaging modality for vFFR due to its ability to 
measure velocity directly. Using PCMR to quantify arterial blood flow in vivo has been 
theoretically and experimentally validated in multiple studies, and has been used as a staple 
of cardiovascular imaging for decades [17, 18, 44, 46]. Its specific utilization in the 
coronary circulation, however, has not been well validated. Therefore, it is the purpose of 
this study to determine if PCMR can be used to measure blood flow in the coronary 
circulation such that the boundary conditions necessary for vFFR calculation can be 
determined.  
Because only time-averaged hyperemic arterial flow is needed to accurately 
calculate vFFR, there are two potential options available to acquire the needed information 




1) The time-resolved hyperemic arterial inflow waveform can be measured directly, 
averaged across time, and then applied as the inlet flow boundary condition. Doing 
so, however, is clinically impractical due to the constraints on adenosine 
administration.  
2) The time-resolved basal arterial inflow waveform can be measured directly and 
averaged across time. Then, the patient-specific CFR can be acquired through 
PCMR of the coronary sinus, and the basal flow rate can be scaled linearly to 
acquire an approximation of the hyperemic arterial flow rate.  
Though direct measurement of coronary arterial flow through PCMR has not been 
well validated, its use in the coronary sinus has been shown to be reliable [47-49]. 
Therefore, to determine if PCMR can directly quantify coronary arterial flow rates, the 
following two hypotheses were tested with regard to PCMR: 1) repeated measurements of 
coronary arterial flow will produce repeatable time-averaged flow rates, and 2) the sum of 
the time-averaged flow rates in the LM and right coronary artery (RCA) will equal the 
time-averaged flow through the coronary sinus. 
5.2 Methods 
Coronary flow was measured in seven volunteers (age 20-65, five female) with no 
previous history of cardiovascular disease. Arterial flow was measured in a total of 13 
vessels (six LM, seven RCA), and venous flow was measured in seven coronary sinuses. 
Informed consent was obtained prior to MRI scans and the study was approved by the 
university’s IRB. All scans were performed on a 3 T scanner (MAGNETOM Prismafit, 




To plan the coronary flow measurements, a stack of 192 transverse slices were 
acquired over the heart during mid-diastole using a navigator-gated 3D whole-heart 
coronary MRA sequence [32, 50]. The navigator beam was placed in the superior-inferior 
orientation over the right hemi-diaphragm and was acquired at the start of each cardiac 
cycle. An acceptance window of 3 mm was used to prospectively gate the acquisition to 
end-expiration. Total time for the MRA stack was approximately 10-20 minutes during 
free-breathing. Following acquisition, multiplanar reformation (MPR) was performed on 
the motion-resolved image volume to isolate 2D planes which passed perpendicularly 
Figure 14: Example images for planning coronary PCMR acquisition. (a) MPR to isolate through-plane view 
of the RCA. (b) MPR to isolate through-plane view of the distal LM and proximal LAD and LCX, following 





through the ostia for each of the LM, RCA, and coronary sinus. Example images from one 
volunteer can be seen in Figure 14. 
The PCMR sequence used for the study was a modification of a navigator-gated 
4D PCMR sequence [45], but set to acquire a single slice with only through-plane velocity 
measurements. A navigator approach was used to increase the effective resolution of the 
scan without creating fold-over artifacts or mandating a very long breath-hold. Again, a 
navigator beam was placed over the right hemi-diaphragm to acquire at the beginning of 
each cardiac cycle as determined through R-peak detection in the subject’s ECG. An 
acceptance window of 1 mm was used to prospectively gate the acquisition to end-
inhalation. If the respiratory position was recorded to be within the acceptance window, 
PCMR measurements were acquired across the entire cardiac cycle and were binned into 
approximately 25 temporal phases depending on the subject’s heart rate. The velocity 
encoding (VENC) parameter was set between 40 and 70 cm/s according to the subject-
specific coronary flow to maximize the dynamic range without introducing aliasing 
artifacts. Each pixel was 1 mm2, and the field-of-view (FOV) and matrix size were variably 
set for each subject to ensure no fold-over artifacts would occur in the image. Acquisition 
Figure 15: Representative image of coronary PCMR flow quantification. (a) Phase image with RCA 
segmented in red. (b) Magnitude image with RCA segmented in red. (c) Resultant flow waveform following 




time for each PCMR scan was approximately five minutes during free-breathing, and 
measurements were acquired for each vessel twice.  
Following data acquisition, images were exported offline and analyzed using the 
freely available software Segment version 2.0 [51]. For each image stack, the magnitude 
and phase images were coupled and used to identify the luminal contours of the target 
vessel. A constant region-of-interest (ROI) was used across each temporal phase, and the 
ROI size was maintained when evaluating repeated measurements of the same vessel. 
Static tissue regions at the chest walls were automatically identified and used to calculate 
a second-order polynomial map to represent the estimated phase error induced by eddy 
current effects and correct for this [51]. The through-plane velocities of the pixels 
contained within the ROI were then added to provide a time-dependent flow waveform, 
from which the time-averaged flow rate could be recorded. An example image showing the 
vessel segmentation and flow waveform extraction can be seen in Figure 15.  
To compare the arterial flow rates against the already validated coronary sinus 
measurements, the coronary arterial flow rates were added together, and the sum was 
compared against the corresponding coronary sinus flow rate. Because duplicate 
measurements were acquired in several of the vessels, all combinations of arterial and sinus 
flow rates were tested individually for correlation, and the best and worst performing sets 
were selected to provide upper and lower bounds for the solution. 
5.3 Results 
A total of 24 coronary artery (13 RCA, 11 LM) and 12 coronary sinus flow 




0.030 L / min (0.045 ± 0.028 for RCA, 0.073 ± 0.025 for LM), and average sinus flow was 
0.122 ± 0.048 L / min. Repeated flow measurements were acquired on 11 coronary arteries, 
and Pearson’s correlation coefficient for the matching pairs was calculated to be r = 0.97 
which is a strong indication of repeatability (Figure 16a). In six volunteers, both coronary 
arterial flow rates and the coronary sinus flow rate were measured. The sums of the arterial 
flow rates were plotted against the sinus flow rates, and the correlation coefficient for the 
relationship was estimated to be between 0.94 and 1.0 (Figure 16b,c). Bland–Altman 
analysis of these measures was also performed, and the concordance coefficient was 
estimated to be between 0.93 and 1.0 (Figure 16d,e).  
Figure 16: Coronary PCMR flow comparison. (a) Time-averaged flow rates of coronary vessels were 
measured with PCMR in seven volunteers. Duplicate measures were acquired in 11 coronary arteries (6 RCA, 
5 LM) and plotted against each other with correlation evaluated via Pearson’s r. Then, the sums of 
corresponding LM and RCA flows were computed and plotted against the coronary sinus flows (b-c), and 
the means of the measures were plotted against the differences (d-e). Because duplicate measures were 
acquired, every combination of of the healthy volunteers (n = 6 for each) was evaluated for correlation with 
Pearson’s r and for concordance with Lin’s ρc, and the best (b, d) and worst (c, e) performing data 





Despite the presence of strong correlative relationships between the time-averaged 
values, an interesting phenomenon was observed from the time-resolved flow waveforms. 
Typically, coronary flow waveforms adhere to a primarily biphasic shape, wherein flow is 
slowed or even reversed during systole and is mostly positive during diastole. Consistently, 
however, a strong positive pulse was observed during systole with a negative pulse seen 
during diastole. When the myocardial tissue adjacent to the arteries was segmented, we 
observed non-zero velocities at many time points throughout the cardiac cycle. Subtraction 
of the myocardial velocity over the arterial cross-sectional area was able to mostly recover 
the expected arterial flow waveform. An example of this can be seen in Figure 17.   
5.4 Discussion 
The results indicate that 1) repeated PCMR measurements of coronary arterial flow 
produce consistent time-averaged flow rates, and 2) the sum of the time-averaged flow 
rates in the LM and RCA equal the time-averaged flow through the coronary sinus, thereby 
supporting both hypotheses. The consistency seen in the repeated flow measures indicates 
Figure 17: Representative LM arterial flow waveform and myocardial tissue motion correction.(a, b) Coupled 
PCMR phase and magnitude images with RCA outlined in red and adjacent myocardial tissue outlined in 
green. (c) Arterial flow waveform measured through segmentation of the RCA luminal contour in each 
temporal phase of the PCMR image data in red. The ‘flow’ measured through the myocardial segmentation 
was recorded and divided by the ROI area to obtain the average tissue velocity. This velocity was then 
multiplied by the arterial ROI area to obtain the amount of measured arterial flow which was caused by 
myocardial motion, plotted in gray. The negative of this waveform was subtracted from the measured arterial 




a relative lack of random error, while the continuity between the arterial measurements and 
sinus measurements indicates a lack of systematic error due to the latter’s aforementioned 
validation [47-49]. Overall, this supports the accuracy of time-averaged coronary arterial 
flow measurements obtained through PCMR.  
The time-dependent velocity offset seen in the flow waveforms, however, does 
create several implications for evaluating coronary flow through PCMR. As described 
earlier, PCMR works through the application of a bipolar gradient which induces a phase-
offset in each particle which is linearly proportionate to the component of the particle’s 
velocity in the encoding direction. The phase offset recorded in each voxel is therefore the 
average of the phase offset of the particles contained within that voxel during the 
acquisition window. Ideally, if the 2D slice is placed such that the coronary vessel runs 
through-plane, then the velocity measured in each voxel would be representative of the 
blood-flow velocity at that location. However, as can be deduced from Figure 17, there is 
a secondary source of motion created by the heart itself. During cardiac contraction, the 
heart rotates which results in a through-plane motion of the myocardium and adjacent 
coronary vessel. Therefore, the velocity recorded through segmentation of the coronary 
lumen in PCMR images is actually the sum of the blood velocity relative to the vessel and 
the vessel’s velocity relative to the fixed external reference.  
The cardiac motion is periodic, meaning that within each cardiac cycle the expected 
net rotation of the heart should be zero. In the example waveform in Figure 17, the time-
averaged flow rate of the waveform without correction was 0.96 mL / s, while the 
‘corrected’ waveform showed an average rate of 0.99 mL / s. This indicates that for the 




the measured value. However, this only holds true so long as the ROI used to measure the 
coronary flow rate is kept constant throughout every temporal phase. If, for example, a 
large ROI is used during systole when ‘positive’ motion is recorded, while a small ROI is 
used during diastole when ‘negative’ motion is observed, then the net influence of the 
cardiac contraction will be non-zero. Furthermore, the through-plane velocity of the 
myocardial tissue will vary with radial distance from the rotational center of the heart. For 
smaller vessels such as the LM and RCA, this variation is not likely to be large enough to 
cause significant effects. However, for individuals with especially large coronary sinuses, 
this may indeed become a source of error.  
This effect can introduce difficulty in coronary PCMR analysis. Though these 
arteries are typically not observed to dilate significantly, the visible cross-sectional area of 
the vessel can change considerably as it moves into and out of the slice. Proximal segments 
of the vessel will be larger than distal portions, and the vessel can shift into an oblique 
position at certain time-points which will create a larger, non-circular intersection with the 
viewing plane. Additional complications can arise in individuals with short LM arteries 
which quickly bifurcate into the LAD and LCX. If the viewing plane is placed such that 
some temporal phases capture both the LAD and LCX while others capture the LM by 
itself, then the combined areas of the ROIs must be carefully monitored such that a constant 
area is maintained. The coronary sinus presents even more difficulties due to its 
distensibility and relative proximity to the heart chambers, namely the left atrium. In many 
individuals, the cross-section of the coronary sinus, especially near the ostium to the right 
atrium, can drastically change in size and ellipticity over the cardiac cycle. Maintaining a 




measurement of flow velocities within the neighboring structures such as the left atrium. 
These effects can produce significant hurdles for full clinical implementation of coronary 
flow measurements.  
Despite these hurdles, if a constant ROI is maintained which contains only the 
through-plane vessel of interest and minimal surrounding myocardial tissue, the 
contribution of the vessel velocity relative to a fixed reference should be negligible once 
the flow-rate is averaged across the cardiac cycle. To calculate vFFR, it was determined 
that only time-averaged coronary flow rates were necessary; therefore, these results appear 
to indicate that it is possible to acquire the flow information needed for vFFR calculation 
through PCMR, if an appropriate image analysis is undertaken.  
However, the time-dependent velocity contribution of the myocardial motion does 
still affect the measured time-resolved waveform. Figure 17 represents a very rough 
approach to approximate the different velocity contributions, but it does not necessarily 
represent a comprehensive solution for fully separating the flow velocity from the vessel 
velocity. As it is, the velocity waveforms obtained through PCMR do not appear to 
accurately portray the true time-resolved coronary flow waveforms. Though this is not 
significant for vFFR calculation, this implies limitations for the use of PCMR in defining 
coronary boundary conditions for computational models wherein the time-dependent 
behavior is critical, such as in calculating wall shear stress. The maximum wall shear stress 
and oscillating shear index of vessels have both been linked with the nucleation and 
progression of atherosclerotic plaques, and study of this area is of particular interest. These 




coronary flow velocity from the vessel velocity, PCMR cannot be used in these 
applications. 
The time-averaged flow rates observed here do show general agreement with what 
has been published previously. In 2008, Johnson et al. published preliminary validation of 
coronary arterial flow measurements in which they reported RCA flow rates of 0.038 ± 
0.019 L / min, LAD flow rates of 0.030 ± 0.017 L / min, and LCX flow rates of 0.028 ± 
0.020 L / min [52]. The average coronary sinus flow rate recorded here—0.122 ± 0.048 L 
/ min—also showed agreement with the 0.107 ± 0.019 L / min reported by Ganz et al. in 
1971 [53]. 
This study does have several limitations. The cohort investigated were healthy 
volunteers, while the utilization of PCMR toward calculating vFFR will primarily be used 
in patients with CAD. Such patients may exhibit irregular breathing patterns or cardiac 
cycles which can complicate the prospective navigator- and ECG-gated scans used for 
planning and acquiring the PCMR flow data. The cohort would also benefit from a larger 
sample size for a more robust statistical analysis. The experiment was designed such that 
the effects of random and systematic error could be quantified; however, user error was not 
considered. Due to the necessary complexity of the flow analysis, reproducibility by 
different operators should also be quantifiably tested as well. 
Lastly, invasive arterial flow measurements were not available for direct 
comparison with the PCMR-derived measurements. Though the coronary sinus flow 
measurements via PCMR have been previously validated against invasive flow 
measurements, this still creates a limitation for the overall results presented here. A future 




measurements or in an animal model would be necessary for full validation. Validation 
could also be provided through a phantom model, which would allow for direct ground-
truth measurements for comparison, though such a model would of course need to be very 
complex to correctly simulate the physiologic processes involved.  
5.5 Conclusion 
The study suggests that the time-averaged coronary flow measurements obtained 
through PCMR and subsequent image analysis can be accurate. The time-dependent flow 
waveform was observed to be a superposition of the blood flow velocity and the vessel 
velocity as the heart moves through the imaging plane. If the ROI is maintained at a 
constant size, the time-averaged contribution from the vessel motion should be negligible, 
therefore allowing the flow measurement to be used for applications wherein time-




CHAPTER 6.  SELF-NAVIGATION CORONARY MRA 
6.1 Introduction 
To calculate vFFR through CFD, the patient-specific coronary anatomic geometry 
must be defined through whole-heart MRA. There are two primary sources of motion 
which must be considered for an acquisition of whole heart coronary anatomy to be 
successful. The first is the contractile motion of the heart itself. Because heart motion is 
typically periodic, this can be handled through ECG-triggering and gating acquisition to a 
quiescent interval of the cardiac cycle—usually mid-late diastole (Figure 18). If data are 
acquired at the same temporal location during each cardiac cycle, then it is expected that 
the heart will be in the same position, thereby reducing motion artifacts. The second source 
of motion is caused by respiration. Due to the amount of data necessary for a whole-heart 
angiogram, the subject cannot be expected to hold their breath over the required time frame. 
Rather, a free-breathing acquisition must be utilized. The most common technique to allow 
for free-breathing whole-heart MRA utilizes the previously described navigator beam. A 
navigator beam can be created by two secant planes oriented such that the line of 
intersection is in the SI direction of the subject. By placing this beam over the right 




hemidiaphragm, a one-dimensional image can be acquired at the start of each cardiac cycle, 
and edge detection within a set positional range can be used to determine the respiratory 
motion state. If this respiratory state is contained within a pre-defined acceptance window, 
then data are acquired; otherwise, the scan acquisition is idle (Figure 4).  
Both of these techniques represent what is known as prospective navigator-gating. 
Positional information about the heart is acquired in real-time and used to determine if data 
will be acquired prior to their acquisition. In individuals with consistent and predictable 
cardiac rhythms and respiratory cycles, such techniques can be very successful. Utilization 
of these techniques toward whole-heart angiography have previously allowed for full three-
dimensional characterization of coronary arteries sufficient for vFFR calculation without 
significant motion artifacts [28]. In practice, however, such protocols can prove 
problematic.  
Prospective navigator-gating requires the operator to identify the relative height of 
the diaphragm at end-inhalation. Tidal volumes, however, can frequently change, which 
can raise or lower the position of the diaphragm at end-inhalation. This can lead to very 
low acceptance rates which can cause unpredictably long scan times. Furthermore, the size 
of the coronary arteries necessitates that the acceptance window must be sufficiently small 
as well so that the effective motion-resolved resolution can accurately characterize the 
vessels, which can further extend scan times. To address these problems, respiratory self-
navigation was first proposed as an alternative in 2005 [19]. The goal of this technique is 
to extract physiologic signals from the raw image data and use these signals to perform 
retrospective motion compensation. The specific approach utilized in this study is fully 




During each cardiac cycle, data are acquired using a three-dimensional spiral 
phyllotaxis k-space trajectory which begins with a radial readout in the SI direction. 
Performing a one-dimensional Fourier transform on this SI readout provides a projection 
of the imaging volume onto the SI axis at the time of acquisition. Cross-correlation of the 
SI projection at each temporal location with a reference projection acquired at the 
beginning of the scan then allows for the absolute displacement of the heart in the SI 
direction to be approximated. Utilization of the Fourier shift theorem—which relates a 
translation in the image domain to a phase offset in the frequency domain—can then be 
used to perform motion correction on the data prior to regridding and image reconstruction 
(Figure 19). This technique, therefore, does not rely on any navigator gating to reduce 
motion artifacts, and has a 100% scan efficiency. This results in a very predictable scan 
time—usually between 4 and 7 minutes, depending on the patient’s heart rate 
This technique has been demonstrated on both healthy volunteers [21] and patients 
[22, 54], and these results support that it affords similar image quality to whole-heart MRA 
with navigator beams. Prior studies, however, have not specifically investigated whether 
this approach could provide images which allow for full three-dimensional segmentation 
and generation of coronary computational models. Furthermore, all prior studies 
investigating the image quality of this technique have been performed by the author of the 




sequence, and it is not known if it is more widely applicable. Therefore, this study sought 
to objectively assess whether the motion-corrected self-navigation whole-heart MRA can 
successfully and consistently provide images which can ultimately be used in the 
calculation of vFFR.  
6.2 Methods 
Images were acquired in 33 patients (12 females; average age 44.4 ± 17.6 years) 
with congenital heart disease (CHD) undergoing clinically indicated cardiac MRI with IRB 
approval. All scans were performed on a 1.5 T MR scanner (MAGNETOM Avantofit, 
Siemens Healthcare) at Emory University Hospital in Atlanta, Georgia. Prior to data 
acquisition, a ventricular long-axis 2D cine was acquired to allow for the approximate 
diastatic window in the cardiac cycle to be determined. A low resolution localizer scan was 
run during free-breathing without cardiac gating over the desired FOV containing the heart. 
Automatic segmentation of the LV blood pool was then performed to determine which coil 
elements were most sensitive in detecting the LV, and this information was stored in the 
scanner PDS memory.  
Images were then acquired using a 3D spiral phyllotaxis acquisition with a balanced 
steady-state free precession (bSSFP) readout over a cubic (220 mm) FOV with an isotropic 
voxel size of 1.15 mm and a flip angle of 115°. Image acquisition was gated to the 
predetermined diastatic temporal window using the patient’s ECG. Following acquisition 
of each interleave, the SI readout lines collected by the two coil elements which were 
determined to be most sensitive to the LV blood pool were transformed to the image 
domain and compared against the reference projection acquired at the start of the scan to 




phase-shifted to correct for this positional offset. Each interleave consisted of 32 radial 
segments, and a total of approximately 375 interleaves were acquired to provide ~12,000 
radial lines of data. Prior to acquisition of each interleave, fat saturation and T2 
magnetization preparatory pulses were applied, and a coronal saturation slab was placed 
over the anterior chest wall to better isolate motion signal from the LV blood pool.  
The vessels of interest—LM, LCX, LAD, and RCA—were each qualitatively 
assessed for clarity on a scale of 0 to 4 by a single observer. A score of 0 indicated that the 
vessel was not visible at all; 1 indicated that only the presence of the vessel was observable; 
2 indicated that the vessel trajectory could be followed for at least 30 mm; 3 indicated that 
some details regarding the vessel geometry could be observed; and 4 indicated that image 
quality was sufficient for the vessel to be fully segmented and used to generate a 
computational fluid model. For each patient, the average of these four scores was then 
calculated to provide an overall score.  
6.3 Results 
Overall, images acquired using the motion-corrected self-navigated whole-heart 
MRA did not appear to adequately provide quality sufficient for full three-dimensional 
characterization of the epicardial vessels. The average overall score for the patients was 
1.7 ± 0.98 with per vessel scores of 2.14 ± 1.15 for LM, 1.15 ± 1.35 for LCX, 1.79 ± 1.08 
for LAD, and 1.7 ± 1.02 for RCA.  
During each scan, the inline display was used to monitor self-navigation. For the 
majority of patients, visual assessment of self-navigation did not meet expectations. For 




the adjacent tissue (Figure 20a). This was not observed in majority of patients scanned 
(Figure 20b). If the navigator was seen to be obviously not working correctly and time 
permitted, the scan was stopped and the position of the FOV and saturation slab were 
adjusted to attempt to correct the motion detection. Frequently, however, these adjustments 
were either not possible to do within the time constraints of the clinical scan or no visible 
differences could be seen in the navigator following adjustments.  
6.4 Discussion 
The results indicate that this implementation of self-gating cannot consistently 
provide the image quality necessary for vFFR calculation through CFD. Considering that 
successful coronary characterization is possible through MRI—both Cartesian [28] and 3D 
radial [21]—it is not suspected that the imaging modality or readout trajectory are 
inherently flawed. Rather, it seems to be the result of the respiratory motion detection and 
Figure 20: Representative view of self-navigation SI projections and LV blood pool detection.  (a) What is 
expected to see from the SI projections with a bright LV blood pool projection and sharp edges delineating 
it from the adjacent tissue signal. (b) What was typically seen in these acquisitions. LV signal was not 
especially bright or easy to identify, and motion detection did not appear to represent an expected respiratory 




subsequent motion correction not performing as expected. More often than not, the LV 
blood pool projection could not be visibly seen in the SI projections, and the respiratory 
signal produced from the cross-correlation algorithm did not usually reflect a 
physiologically typical breathing pattern. Because tidal volumes can shift the diaphragm 
position by 10 or 20 mm during each breath, it is not surprising that inaccurate respiratory 
motion correction and subsequent artifacts can mostly or completely obstruct visibility of 
the coronary arteries.  
 There were several factors which may have contributed to the self-navigation not 
functioning as intended. The LV blood pool signal was not as strong as expected, which 
may have been due to the automatic LV segmentation and optimal coil selection not 
working successfully. It is possible that this was a result of the population recruited. 
Because these were congenital patients, many of them had anomalous anatomy, which may 
not have worked with the algorithm used to automatically detect and segment the LV blood 
pool. This, however, would appear to be an oversight as whole-heart MRA is very 
frequently employed in congenital patients to aid in planning functional scans where the 
anatomy may be atypical. Furthermore, comorbidity of CAD in patients with CHD is over 
four times greater than in patients without CHD (p < 0.001) [55].  
Though the LV blood pool signal was not strongly visible on the navigator, visual 
inspection of the SI projections could usually identify a possible respiratory pattern (Figure 
20b). It was therefore suspected that a more robust motion detection approach could instead 
be utilized on the acquired data, which could allow for successful motion compensation. 
The method used in this technique seems particularly sensitive to unexpected respiratory 




therefore result in discontinuous signals, an example of which can be seen in Figure 20b. 
Furthermore, successful cross-correlation of the LV requires that 1) the automatic 
segmentation of the ventricle is correctly performed, 2) the corresponding coil elements 
with the strongest signal contribution from the LV are identified, and 3) the LV signal is 
very bright against the neighboring tissue and shows a strong, consistent delineation. If any 
one of these does not perform as expected, then the resulting motion detection can become 
inaccurate. Lastly, this approach assumes that the respiratory motion is entirely within the 
SI direction, and that the heart moves rigidly without rotation. Even if both of these 
assumptions are invariably correct for all patients—which they frequently are not—this 
relies on the patient lying perfectly in alignment with the MR scanner.  
The methods presented here are not without limitations. The heuristic evaluation of 
the vessel quality is qualitative, and arguably more substantial metrics could instead be 
used, such as vessel sharpness, signal-to-noise ratio, etc. Furthermore, comparison of these 
image sets against images acquired with alternate modalities—such as CT—could provide 
objective validation of the potential of these images in three-dimensional coronary 
segmentation. However, considering that the images underperformed as much as they did, 
it was determined that such metrics would not be necessary. It was visually apparent that 
these images could not be used for the intended application of calculating vFFR, and 
therefore attempting to quantitatively validate these images would not be worthwhile.  
6.5 Conclusion 
The images acquired through self-navigated, motion-compensated, whole-heart 
MRI were determined to be of suboptimal quality for full three-dimensional coronary 




inability of the LV cross-correlation motion-detection algorithm, and subsequent motion-
correction. The underlying principle—extracting physiologic signals from a 3D radial k-
space trajectory—did not, however, appear to be inherently flawed. Therefore, utilization 
of this principle with a more robust motion-detection and compensation algorithm could 




CHAPTER 7.  RESPIRATORY MOTION–RESOLVED 4D-
GRASP CORONARY MRA 
7.1 Introduction 
In Chapter 5, it was concluded that using image self-navigation for absolute LV 
positional tracking during free-breathing and subsequent motion-correction could not 
consistently provide the image quality needed for reconstruction of the 3D coronary 
anatomy and vFFR calculation. Recent publications have utilized the underlying principle 
of self-gating toward motion-compensation in ways which should be more robust, 
particularly with regard to the suspected failures of the previously investigated technique—
hereafter referred to simply as ‘self-navigation MRA’.  
In 2015, Chandarana et al. first published preliminary feasibility of the novel 
reconstruction framework XD-GRASP [56], which was followed the next year with a more 
comprehensive explanation and investigation by Feng et al. [25]. The golden-angle radial 
sparse parallel (GRASP) acquisition technique utilizes a sparse radial sampling scheme 
with repeated k-space center samples which could then be combined with compressed 
sensing reconstruction to recover the desired image [57, 58]. Owing to the similarities in 
the k-space trajectories, combining GRASP with the principles of self-gating was a logical 
next step as it would theoretically afford improvement of both techniques.  
The acquisition used in self-navigation MRI provides a fully sampled k-space 
volume from which the image volume can be reconstructed. If the physiologic signals 
contained within the k-space data are extracted and then used to bin the collected 




multiple artificially undersampled data sets which can be reconstructed using compressed 
sensing strategies. The application of this technique for respiratory motion–resolved 
whole-heart imaging was first described by Piccini et al. in 2016 [24] and is hereafter 
referred to as ‘4D-GRASP MRA’.  
Binning the data rather than applying motion-correction affords several advantages 
to 4D-GRASP MRA over self-navigation MRA. For accurate motion-correction, the 
absolute three-dimensional positional displacement of the heart needs to be known for each 
data interleave. This requires an algorithm that can provide absolute displacement 
measurements—such as a cross-correlation of the LV blood pool SI projection against a 
reference projection. This was already discussed in Chapter 6 to be sensitive to erroneous 
input and unexpected behavior, and also relies on the assumptions that the respiratory 
motion of the heart is a strict translation in the SI direction and the patient is in perfect 
alignment with the scanner. Furthermore, aligning data such that the heart is always in the 
same position artificially creates motion artifacts in static tissue.  
4D-GRASP MRA, however, has fewer constraints regarding the physiologic 
motion signal. Binning data acquired during similar respiratory phases automatically 
enforces that respiratory motion–induced artifacts are minimized within each bin, meaning 
that no motion-correction is needed prior to reconstruction. This removes the need to 
measure absolute positional displacement, allowing for more relative measures of the 
physiologic state such as independent component analysis (ICA) of the k-space center 
amplitude [24] or principal component analysis (PCA) of the SI projections [59] which are 
both potentially more robust in detecting motion than the LV cross-correlation approach. 




direction, either, only that 1) a sufficient component of the motion is in the SI direction to 
create a measurable signal and 2) the motion is periodic and does not exhibit significant 
hysteresis. Furthermore, 4D-GRASP MRA also produces a four-dimensional image: three 
spatial dimensions and one respiratory position dimension.  
The 4D-GRASP technique had previously been applied in a small cohort of both 
patients and volunteers, and the vessel quality seen in the resulting images was evaluated 
to be greater than or equal to that seen in images from self-navigation MRA [24]. However, 
again, these images were not evaluated for their ability to provide a full three-dimensional 
characterization of the coronary arteries. Therefore, the purpose of this study was to 1) 
more comprehensively compare the images acquired by 4D-GRASP MRA with those 
produced by self-navigation MRA and 2) evaluate the ability of 4D-GRASP MRA to 
sufficiently characterize three-dimensional coronary geometry for determination of the 
geometric boundary conditions needed for calculation of vFFR.  
7.2 Methods 
Images were acquired in 23 patients (age = 39.8 ± 17.4, 10 female) with congenital 
heart disease who were undergoing a clinically indicated cardiovascular MRI at Emory 
University Hospital on a 1.5 T scanner (MAGNETOM Avantofit, Siemens Healthcare) with 
a multi-element array coil following IRB approval. Data were acquired using the same 
acquisition scheme, motion-correction, and reconstruction framework described in Chapter 
6. Additionally, the raw k-space data—prior to motion-correction—were exported for 




Offline reconstruction of the undersampled data sets was performed using a k-t 
sparse sensitivity-encoding (SENSE) algorithm [24, 26], exploiting sparsity in the 
respiratory dimension. All calculations were completed in MATLAB (MathWorks) to 
solve the optimization equation: 
𝑚 =  arg min
𝑚
 ‖𝐹 ∙ 𝐶 ∙ 𝑚 − 𝑑‖2
2  + 𝜆𝑐‖𝐷𝑐 ∙ 𝑚‖1 + 𝜆𝑟‖𝐷𝑟 ∙ 𝑚‖1    
where m is the five-dimensional image; F is the nonuniform fast Fourier transform 
operator; C is the coil sensitivity map; d is the k-space data; Dc and Dr are the first order 
difference operators along their respective dimensions; and λc and λr are the regularization 
weights for their respective dimensions. Prior to the offline reconstruction, the respiratory 
motion signal was extracted through the one-dimensional Fourier transform of the SI k-
space lines and PCA of the temporal projection. Each interleaf was then binned into one of 
four respiratory positions as determined by the motion signal, such that each bin contained 
the same number of data sets [24]. A visualization of the overall methodology can be seen 
in Figure 21. 
For each subject, the vessels of interest—LM, LCX, LAD, and RCA—were each 
qualitatively assessed for clarity on a scale of 0 to 4 by a single observer as described in 
the previous chapter. A score of 0 indicated a complete inability to see the vessel, while a 




score of 4 indicated that the vessel had full three-dimensional characterization. This was 
performed for image sets reconstructed for each set of data both online (self-navigation 
MRA) and offline (4D-GRASP MRA).  
The 4D-GRASP MRA vessel scores were evaluated with a one-sample, one-tail t-
test against the hypothesis of a score of 4 both individually and when grouped together. 
Additionally, each vessel from the 4D-GRASP MRA was compared against the 
corresponding vessel from the self-navigation MRA using a paired, one-tail t-test to 
evaluate if the increase in score was significant, both individually for each vessel and when 
all vessels were grouped together.  
7.3 Results 
The overall image quality score for all vessels evaluated from the 4D-GRASP MRA 
images sets was 2.34 ± 1.07. Individual vessel scores were 3.00 ± 0.90 for LM, 1.70 ± 1.11 
Figure 22: Vessel score results from images reconstructed using 4D-GRASP MRA. (a) All vessels were 
qualitatively evaluated on a scale from 0 to 4 for ability to characterize the three-dimensional coronary 
geometry.Significance was seen for each individual vessel (n = 23) and all vessels grouped together (n = 92) 
when compared against the null hypothesis of 4 with a one-sample, one-tail t-test (p < 0.001). (b) Vessel 
scores from the 4D-GRASP MRA images were then subtracted by the corresponding scores for the self-
navigation MRA images, and these differences were plotted individually for each vessel (n = 23) and when 
grouped together (n = 92). Score differences were evaluated with a one-tail, one-sample t-test against the null 
hypotheses of 0 indicating no significant difference from self-navigation MRA to 4D-GRASP MRA. All 





for LCX, 2.39 ± 0.94 for LAD, and 2.26 ± 0.96 for RCA (Figure 22a). All vessel groups 
were seen to be significantly below 4. In total, of the 92 vessels assessed, only 14 of the 
4D-GRASP MRA group achieved a score of 4, though this was higher than the self-
navigation MRA group which only had four vessels achieve a score of 4. On average, 4D-
GRASP MRA was seen to give higher scores for all vessels combined as well as for the 
LM, LCX, and RCA (Figure 22b) (Figure 23).  
The SI projections and resultant motion tracking was observed visually to be much 
more successful with the PCA approach used in 4D-GRASP MRA than the cross-
correlation approach used in self-navigation MRA. An example comparison can be seen in 
Figure 24. Both motion-tracking images come from the same data set, and though some 
respiratory motion can be seen in the projections in Figure 24a, the cross-correlation–based 
approach does not appear to successfully track this. Conversely, a much more compelling 
respiratory signal can be seen from the PCA in Figure 24b.  
Figure 23: Representative comparison of two images acquired from the same data set using (a) the self-





Overall, 4D-GRASP MRA showed improvement over self-navigation MRA in a 
direct, paired comparison. Due to the improvement seen in the respiratory motion tracking, 
this is likely a large contributing factor. PCA was seen to be generally more robust for 
handling data were the LV projection was not clearly identifiable on the navigator images 
and therefore would not be easily detected through cross-correlation with a reference 
image. The ability to correctly track the respiratory motion is integral for both 
reconstruction approaches to work, and it therefore yielded an improvement in the vessel 
quality.  
Other factors may have also contributed to the improved quality. Beyond the 
motion-tracking methods, 4D-GRASP MRA also differs from self-navigation MRA in that 
it bins the data rather than attempting to correct the motion. This makes 4D-GRASP MRA 
Figure 24: Representative comparison of (a) LV cross-correlation motion tracking and (b) PCA motion 




less susceptible to artificial motion induction in the static tissues of the image. The 4D-
GRASP motion-compensation is not reliant on absolute displacement measurements, nor 
does it rely on an assumption of a purely superior-inferior respiratory motion.  
The measured improvement of 4D-GRASP MRA over self-navigation MRA agrees 
with a previously published comparison primarily in healthy volunteers and was therefore 
expected [24]. Though an overall improvement in image quality was observed, the images 
were still not deemed to be acceptable for full three-dimensional coronary characterization. 
More individual vessels were seen to be of sufficient quality, but the population as a whole 
did not have the image quality needed. There are several factors which may have 
contributed to this.  
First, although the respiratory signal recovered through PCA was visually observed 
to more accurately represent the SI projections, it was not quantitatively validated against 
the true respiratory position, as this would be difficult or impossible to do. Because the 
images do show a relative lack of respiratory motion artifacts, it can be assumed that some 
degree of compensation was achieved, though of course there may be errors, such as 
blurring, which are difficult to detect. Furthermore, the self-navigated approach does 
assume that the respiratory position remains constant throughout the duration of each data 
acquisition, and bins the entire interleaf based on the physiologic state exhibited when only 
the first line of k-space was acquired. Each data acquisition occurred over approximately 
150 ms, which is relatively short compared to the period of a breathing cycle, but a 
significant amount of motion may occur during this time. Attempting to correct for this, 
however, would require an interpolation of the respiratory position between each 




fundamentally difficult due to the unpredictable and variable nature of the respiratory 
cycle.  
 The k-t SENSE algorithm used to reconstruct the undersampled data takes 
advantage of compressed sensing strategies to recover information in the reconstructed 
image, but the data are still inherently undersampled. Acquisition of more interleaves to 
reduce the reliance on k-t SENSE may help improve image quality, however this would 
result in increased acquisition time.  
Another likely source of error can be attributed to the prospective cardiac-gating. 
The acquisition time was prospectively set to occur during mid-late diastole; however, this 
did not always occur consistently. Many patients’ heartrates were observed to change over 
the course of the 5-7 minute scan, which would often result in the acquisition occurring 
earlier in the cycle at end-systole or early-diastole, or it may occur too late in the cycle and 
be interrupted by the R-peak detected at the beginning of the next cycle. Furthermore, many 
patients exhibited end-diastolic stasis windows which were significantly shorter than the 
150 ms needed for the acquisition. Correcting for this without reducing the total number of 
samples acquired would have required a much longer acquisition, however this might be 
preferable for these patients. In a small subset of patients, the acquisition itself would 
induce an artifact in the recorded ECG which would be detected as an R-peak. When this 
occurred, acquisition would be interrupted consistently during each heart-beat. Usually, 
however, when this was observed, the acquisition would be aborted early and attempted 





Images acquired through 4D-GRASP MRA were seen to offer overall improvement 
on the vessel quality as compared with self-navigation MRA. This can likely be attributed 
to the improved motion tracking afforded by PCA, though other factors may also be 
involved. Image quality afforded by 4D-GRASP MRA was not, however, seen to be 
sufficient for full three-dimensional vessel characterization, and therefore cannot be used 
for consistent vFFR calculation. It is suspected that cardiac motion may still be a significant 
factor in degrading the image quality, specifically with regards to the acquisition window 




CHAPTER 8.  RESPIRATORY AND CARDIAC MOTION–
RESOLVED 5D-GRASP CORONARY MRA 
8.1 Introduction 
Although 4D-GRASP MRA could not consistently acquire images of sufficient 
quality for vFFR calculation, there was a definite improvement over self-navigation MRA 
presumably due to the increased robustness of the methodology used to compensate for 
respiratory motion. PCA of the SI projections to calculate a relative measure of respiratory 
motion proved to more reliable than attempting to determine the three-dimensional 
displacement of the heart through cross-correlation of the LV blood pool. Binning the data 
according to respiratory motion state inherently minimizes motion artifacts within each 
bin, and compressed sensing reconstruction was capable of recovering information from 
undersampled data. 
One of the major advantages offered by 4D-GRASP MRA is shared with self-
navigation MRA: retrospective navigation to compensate for respiratory motion. 
Prospectively gating image acquisition according to respiratory position can be sensitive 
to changes in the respiratory pattern. For the acquisition to be successful, the subject’s 
breathing needs to remain constant throughout the duration of the acquisition. Conversely, 
retrospective navigation can much more easily adapt to changes in the respiratory pattern, 
allowing for more consistently reliable acquisition.  
To further improve upon 4D-GRASP MRA, this same rationale can be extended 
and applied to the other primary source of motion during a whole-heart MRA—cardiac 




as ‘5D-GRASP MRA’. A five-dimensional whole-heart MRA utilizing the XD-GRASP 
reconstruction framework was first described by Feng et al. in 2018 [26], however the 
methodology used in this study more closely resembles the technique described by Sopra 
et al. in 2019 [27]. For 5D-GRASP MRA, a golden angle readout initiating from an SI 
radial line is used to perform a continuous, free-running data acquisition without 
prospective respiratory gating or ECG triggering. Performing PCA on the SI projections 
will therefore yield a physiologic signal which is a superposition of both respiratory motion 
and cardiac motion. By separating these signals, the specific cardiac temporal phase and 
respiratory position exhibited by the subject at the time of each interleaf acquisition can be 
determined, and binning can be performed accordingly. The result is a whole-heart image 
volume which is resolved across both the cardiac and respiratory cycles—i.e., a five-
dimensional image (Figure 25).  
The benefits afforded to the implementation of retrospective navigator-gating are 
also true for retrospective cardiac-gating. Rather than prescribing the acquisition window 
to occur at a fixed time delay following detection of an R-peak, temporal phases within the 
cardiac cycle are determined by relative temporal location. This allows the algorithm to 
adapt to changes in the subject’s heart rate in the same way that 4D-GRASP MRA could 
adapt to changing respiratory behaviors. The result, theoretically, should be a more reliable 




whole-heart MRA. In practice, this approach has shown preliminary success, though only 
in healthy volunteers [26, 27].  
Transitioning from a prospective cardiac-gated acquisition to a free-running, 
ungated acquisition does, however, introduce one major drawback. The acquisition scheme 
used in both self-navigation MRA and 4D-GRASP MRA employs a series of preparatory 
pulses prior to data collection. First, a T2 prep module consisting of nonselective 
radiofrequency (RF) pulses saturates tissues with short T2 values, such as the myocardium, 
thereby accentuating signal from blood. Next, a fat saturation pulse suppresses the 
epicardial fat which surrounds the coronary arteries. Lastly, a saturation slab on the anterior 
Figure 26: Comparison of acquisition schemes. (a) In a prospectively cardiac-gated sequence, acquisition 
(green) is limited to mid-late diastole and is preceded by a series of preparatory pulses (blue). Otherwise, the 
scan is idle. (b) In a continuous acquisition, the preparatory pulses significantly worsen the temporal 




chest wall suppresses chest motion which could otherwise obstruct LV blood pool motion-
detection and produce fold-over artifacts which would manifest as radial streaking. The 
total time necessary for these preparatory pulses—approximately 100 to 150 ms—is 
usually negligible when acquisition is limited to only once per cardiac cycle (Figure 26a). 
When data acquisition is occurring continuously to fully resolve images across the cardiac 
cycle, however, these preparatory pulses can reduce effective the temporal resolution of 
acquisition by more than half (Figure 26b-c). Furthermore, application of these preparatory 
pulses can disrupt the steady-state free precession (SSFP) used to maintain a transverse 
coherence, which can significantly deteriorate the image quality. To address this problem, 
we considered three different solutions.  
1. The first was the utilization of the bSSFP sequence described by Sopra et al. [27] 
without the T2-prep or the saturation slab. The signal intensity for a bSSFP sequence 
is directly related to the ratio of T2 / T1 which naturally produces contrast between 
blood and myocardium [60], and fat-suppression was used to reduce the epicardial 
fat signal.  The drawback to this method is that the lack of anterior chest wall 
suppression could affect motion-detection and produce streaking artifacts, and the 
blood-myocardium contrast would be reduced without the T2-prep pulse.  
2. The second solution used a spoiled–gradient echo (GRE) sequence with gadolinium-
based contrast agent. A spoiled-GRE sequence is designed to disrupt T2 coherences, 
thereby resulting in a T1-weighted image. Because gadolinium is strongly 
paramagnetic, it reduces blood T1 following injection. By shortening the T1 in blood 
and disrupting T2 coherences, the resulting image should preferentially provide 




gadolinium very quickly begins to perfuse into the surrounding myocardial tissue, 
thereby reducing the contrast afforded between the myocardium and blood as a 
function of time. The time-scale over which this occurs is on the order of minutes, 
meaning the window during which the gadolinium can be effectively used is limited. 
Due to the number of radial lines needed for a five-dimensional image reconstruction, 
the free-running acquisition lasts for approximately 10 minutes. Even if contrast is 
still afforded by the gadolinium throughout this acquisition, the relative signal 
intensities of the blood and myocardium would not remain constant. Therefore, the 
outcome of this approach could not be fully anticipated.  
3. The third solution considered was use the of ferumoxytol, an MRI contrast agent, 
combined with a spoiled-GRE acquisition. Ferumoxytol is a superparamagnetic iron 
oxide–based drug which has been primarily used to treat anemia but has shown great 
potential for off-label diagnostic use as a T1 shortening contrast agent for 
cardiovascular MRA. At a concentration of 4 mg Fe / kg body weight, the T1 of blood 
has been shown to decrease from 1990 ± 573 ms to 80 ± 42 ms, with an in vivo R1 
relaxivity of 12 mM-1 s-1 at 1.5 T [61]. By comparison, the R1 relaxivities of 
gadolinium-based agents are usually in the range of 4 to 5 mM-1 s-1 at 1.5 T [62]. 
With a spoiled-GRE T1-weighted acquisition, this very preferentially increases blood 
signal intensity in the images. Furthermore, the particle size of ferumoxytol is 
substantially larger, preventing it from leaving the vasculature. Without redistribution 
into the extravascular space, the concentration differential between blood and 




approximately 10 to 14 hours [61]. Therefore, the properties of ferumoxytol make it 
particularly well-suited for use in 5D-GRASP MRA.  
The purpose of this study was to investigate the use of ferumoxytol-based contrast-
enhancement in 5D-GRASP MRA to determine if it could provide full three-dimensional 
characterization of the coronary vasculature. Though its success was expected, the other 
two 5D-GRASP MRA approaches described were also pursued to potentially identify more 
clinically feasible alternatives to ferumoxytol. Testing of the non-contrast–enhanced SSFP 
acquisition and the gadolinium-enhanced spoiled-GRE acquisition was performed in two 
separate cohorts of patients with CHD, while the ferumoxytol-enhanced protocol was 
tested in a cohort of pigs.  
8.2 Methods 
8.2.1 Non-Contrast, bSSFP 1.5 T Free-Running Acquisition 
Imaging was performed in nine patients (age = 46.4 ± 17.3 years, five female) with 
congenital heart disease who had been clinically indicated for cardiovascular MRI at 
Emory University Hospital on a 1.5 T scanner (MAGNETOM Avantofit, Siemens 
Healthcare) with a multi-element array coil with IRB approval. Data were acquired using 
a previously reported free-running, three-dimensional radial bSSFP sequence [23]. The 
sequence employed a continuous, ungated acquisition (Figure 26c) over a 192 x 192 x 192 
mm3 FOV with 192 samples per readout, giving an isotropic spatial resolution of 1 mm3. 
Excitation utilized a non-slice-selective RF pulse with a 71° flip angle which was preceded 
by a chemically shift–selective fat saturation pulse and 10 linearly increasing ramp-up RF 
pulses. A total of 107,932 radial readouts were acquired with 22 segments per interleaf 




occurred over 83 ms. Following the scan, the anonymized raw data were exported offline 
for reconstruction. 
8.2.2 Gadolinium-Enhanced, Spoiled-GRE 1.5 T Free-Running Acquisition 
Imaging was performed in 13 additional patients (age = 49.15 ± 16, nine female) 
with congenital heart disease who had been clinically indicated for cardiovascular MRI at 
Emory University Hospital on a 1.5 T scanner (MAGNETOM Avantofit, Siemens 
Healthcare) with IRB approval. Data were acquired using a continuous, free-running, 
golden-angle radial spoiled-GRE sequence over a 192 x 192 x 192 mm3 FOV with 192 
samples per readout, giving an isotropic spatial resolution of 1 mm3. Excitation used a 15° 
flip angle and was preceded by a shift-selective fat saturation pulse and 10 linearly 
increasing ramp-up pulses. A total of 107,932 radial readouts were acquired with 22 
segments per interleaf over a total, constant scan time of 7 minutes and 45 seconds. 
Acquisition of each interleaf occurred over 79 ms. Immediately prior to data acquisition, 
0.01 mmol / kg of gadoteridol was injected into each patient. Following the scan, the 
anonymized data were exported offline for reconstruction. 
8.2.3 Ferumoxytol-Enhanced, Spoiled-GRE 3 T Free-Running Acquisition 
Imaging was performed in a cohort of three hypercholesterolemic Wisconsin 
miniature pigs at the Emory School of Medicine Center for Systems Imaging Core on a 3 
T scanner (MAGNETOM Prismafit, Siemens Healthcare) under an IACUC approved 
protocol in collaboration with the Emory University School of Medicine Heart Research 
and Innovation Laboratory. Prior to scanning, each pig was anesthetized, intubated, and 
placed on respiration. Ferumoxytol at a concentration of 4 Fe mg / kg was dissolved into 




a saline flush. The pigs were then placed in the scanner head-first and supine. Data were 
acquired with a continuous, ungated, golden-angle radial spoiled-GRE sequence over a 192 
x 192 x 192 mm3 FOV with 192 samples per readout, giving an isotropic spatial resolution 
of 1 mm3. Excitation used a 15° flip angle and was preceded by 10 linearly increasing 
ramp-up pulses. A total of 129,000 radial lines were acquired with 22 segments per 
interleaf. Acquisition of each interleaf occurred over 66 ms, and the time required to sample 
all 5983 interleaves was 6 minutes and 29 seconds. Following acquisition, the raw data 
were exported offline for reconstruction. 
8.2.4 Physiologic Signal Extraction and Binning 
For all data sets, cardiac and respiratory motion signals were extracted from the raw 
data using a previously reported methodology via MATLAB (MathWorks) [27]. For a 
given interleaf, the first radial line oriented in the SI direction for each coil was one-
dimensionally fast Fourier transformed to give a projection of the volume at the time of 
acquisition. Projections from each coil were stacked, and then concatenated temporally. 
Subsequent PCA of the resulting temporally-resolved SI projection matrix produced a 
physiological motion signal which spanned the duration of the sequence acquisition. The 
major components contained within this signal represented both cardiac and respiratory 
motion. To separate these two signal components, the power spectral density (PSD) of the 
first 10 principal components was computed and analyzed to determine the frequency 
center of mass of the cardiac motion, starting with frequencies between 0.5 Hz and 2.0 Hz. 
A similar methodology was then used to identify the respiratory signal beginning with 




separated, data were binned into four respiratory states and a variable number of cardiac 
phases determined such that each phase represented a 50 ms window (Figure 25).  
8.2.5 Image Reconstruction 
Image reconstruction of the highly undersampled data sets was then performed 
using the SENSE algorithm [24, 26] exploiting sparsity in both the cardiac and respiratory 
dimensions. All calculations were performed in MATLAB (MathWorks) on a server 
equipped with two 24-core CPUs, 384 GB RAM, and an 11-GB NVIDIA GPU. 
Reconstruction was performed to solve the optimization equation: 
𝑚 =  arg min
𝑚
 ‖𝐹 ∙ 𝐶 ∙ 𝑚 − 𝑑‖2
2  + 𝜆𝑐‖𝐷𝑐 ∙ 𝑚‖1 + 𝜆𝑟‖𝐷𝑟 ∙ 𝑚‖1    
where m is the five-dimensional image; F is the nonuniform fast Fourier transform 
operator; C is the coil sensitivity map; d is the k-space data; Dc and Dr are the first order 
difference operators along their respective dimensions; and λc and λr are the regularization 
weights for their respective dimensions.  
8.2.6 Regularization Parameter Optimization 
The optimization equation used to iteratively calculate the image volume attempts 
to find a solution which minimizes the summation of three separate components. The first 
of these components represents the error associated with the transform of the image and 
the recorded data. The other two components each represent the differences between 
adjacent motion states along the cardiac and respiratory dimensions. These components, 
therefore, attempt to enforce a continuity along each of these dimensions which must then 
be balanced against the error minimization. The values prescribed to each of the two 




determination of the optimal values for these parameters is critical for success of the image 
calculation. 
The options currently available to predictively optimize these parameters are 
limited. Rather, they need to be optimized experimentally. Furthermore, the relative 
Figure 27: Representative display for regularization parameter optimization. (a) A coarse array of 
regularization parameters were used to reconstruct images from the raw data. (b) The SNR of the blood was 
then sampled for each of these reconstructions and used to determine a local maximum within the array. (c) 
A more granularized array was then selected and used for reconstruction, (d) followed by further refinement 




weights can vary substantially for different cohort demographics and acquisition schemes. 
Therefore, for each of the three acquisition schemes utilized in this study, a single data set 
was used to perform an experimental optimization of these two parameters. First, a coarse 
array of values was set, and images were reconstructed for each value combination (Figure 
27a). To quantitatively compare each parameter combination, the signal-to-noise (SNR) of 
the aortic blood pool was calculated. For this, a single transverse slice was chosen which 
contained the aortic trunk near the coronary ostia. The aortic lumen was manually traced, 
and the mean signal intensity was calculated, then divided by the standard deviation of the 
signal to give an estimation of the blood pool SNR. The voxels used for this calculation 
were stored in memory and used to perform the same SNR calculation for each parameter 
combination, and the region of the array with the local maximum was identified (Figure 
27b) and used to select a more granular array of values with which to repeat the experiment 
(Figure 27c-d). This was repeated until an optimal parameter set was identified, which was 
then used to reconstruct all other images within that image group. 
8.2.7 Image Quality Evaluation 
All reconstructed image sets were evaluated heuristically for all three techniques 
by scoring the epicardial vessels—LM, LAD, LCX, and RCA—on a scale from 0 to 4 as 
described in the previous chapter, again with 0 indicating a complete inability to detect the 
vessel and 4 indicating excellent three-dimensional characterization sufficient for use in a 




8.2.8 Ejection Fraction  
For further validation of the cardiac binning of the data, the ejection fraction (EF) 
for a subset of patients was calculated using 1) the short-axis LV cine stack acquired as 
part of the routine clinical scan and 2) an MPR of the five-dimensional image set used to 
create a short-axis LV cine stack. For each cine stack, clinical or reformatted, Simpson’s 
method of discs was used to estimate the end-diastolic volume (EDV) and end-systolic 
volume (ESV) which were then used to compute the EF. Comparison between values was 
performed through calculation of the linear correlation coefficient. MPR of the cardiac-
resolved image volume (Figure 28) and generation of the simulated cine stack (Figure 29) 
Figure 28: Example MPR of cardiac-resolved image volume. (a) Original configuration of orthogonal slices 
in the axial, coronal, and sagittal views, respectively. (b) Reformatted volume showing short-axis view of the 




was performed via MATLAB (MathWorks), and calculation of EDV and ESV was 
performed via Segment version 2.0. For each case, the mean signal of the LV blood pool 
was calculated at the short-axis view located mid-ventricle and was divided by the mean 
signal of the septal myocardium in the same view. This was done through manual 
segmentation. Paired comparison was performed between 5D MPR and 2D cines.  
8.2.9 Limited Dimension Reconstruction 
In two of the ferumoxytol-enhanced five-dimensional acquisitions, a series of 
additional reconstructions were performed utilizing a limited cardiac dimension. Using 
previously reconstructed cardiac-resolved image sets, the cardiac phase visually 
determined to occur during diastasis was selected. Then, rather than use the entire array of 
cardiac phases for the reconstruction, only the end-diastolic stasis phase and a limited 
number of adjacent phases were used (Figure 30). For each raw data set, this limited 
Figure 29: Example of short-axis cine stack generation from 5D-GRASP MPR. (a) Long-axis view of the LV 




dimension reconstruction was repeated with a variable number of adjacent phases ranging 
from zero to four. For each limited reconstruction, 1000 voxels were selected at random 
from the diastasis volume at end-inspiration and compared against the same voxels in the 
corresponding volume from the fully-reconstructed image set through calculation of 
Pearson’s correlation coefficient and structural similarity (SSIM) index.  
8.3 Results 
8.3.1 Reconstruction 
Reconstruction for each five-dimensional image required a significant amount of 
computational power. Memory usage varied for each data set, but it was observed to use 
approximately 100 to 200 GB at any given time. The time needed for each reconstruction 
also varied depending on the specific data asset and the combination of regularization 
parameters used but was observed to take from 12 to 30 hours.  
Figure 30: Visual representation of limited dimension reconstruction. If a data set was binned into 10 cardiac 
phases, then in the normal reconstruction all 10 phases would be used. In the limited dimension 
reconstruction, the diastasis phase—7 in this case—was identified, and a limited number of adjacent phases 




8.3.2 Heuristic Evaluation 
The images acquired from the three separate acquisition groups were evaluated 
heuristically by qualitatively assessing the quality of each epicardial vessel—LM, LAD, 
LCX, and RCA—on a scale of 0 to 4. The average score for each vessel was observed to 
be consistently higher with the gadolinium-enhanced, spoiled-GRE acquisitions (1.15 ± 
1.04) than for the non-contrast–enhanced, bSSFP acquisition (0.78 ± 0.76), however 
differences were not found to be significant between groups when compared together or 
on a per-vessel basis (Figure 32). Significant differences were seen when comparing either 
the vessels individually or the acquisition group as a whole against the null hypothesis of 
µ0 = 4. Additionally, none of the 88 vessels from either group were evaluated to be of 
sufficient quality for use in computational fluid modeling. The ferumoxytol-enhanced, 
spoiled-GRE acquisition, however, was observed to perform substantially better than the 
other two groups (Figure 31) (Figure 33).   
Figure 31: Typical results are shown. (a) Reformatted image volume showin the LM and LAD. (b) 





Figure 32: Vessel quality scores for patients imaged with the gadolinium-enhanced, spoiled-GRE acquisition 
(5D-Gd) (n = 52, N = 13) and patients imaged with the non-contrast–enhanced, bSSFP acquisition (5D-NC) 
(n = 9, N = 36). No significant differences were observed through unpaired t-test comparison of the vessel 
quality either invidually or combined (α = 0.05). Significant differences were seen, however, for all groups 
when compared against the µ0 = 4 (α = 0.05). 
Figure 33: Comparison of vessel scores for all self-navigated methods tested including non-contrast, bSSFP 
self-navigation MRA (SN-NC), non-contrast, bSSFP 4D-GRASP MRA (4D-NC), non-contrast, bSSFP 5D-
GRASP MRA (5D-NC), gadolinium-enhanced, spoiled-GRE 5D-GRASP MRA (5D-Gd), and ferumoxytol-




8.3.3 Ejection Fraction 
The EF values computed with reformatted 5D-GRASP MRA images acquired with 
an SSFP acquisition were seen to correlate very strongly with the corresponding values 
Figure 34: Comparison of EF calculated through MPR of 5D-GRASP coronary MRA and EF calculated 
through 2D cines (n = 6). (a) The EF values computed with both techniques were plotted against each other 
with correlation evaluated through Pearson’s r. (b) Ventricular blood pool signal relative to myocardial 
septum in 2D cines and reformatted 5D images were seen to be significantly different for both the right and 
left ventricles. (c) Example of reformatted 5D image in ventricular short-axis view. (d) Example of 





found using the 2D cines acquired as part of the routine clinical scan (Figure 34a). Image 
quality was observed to be generally worse in the 5D MPR images (Figure 34c-d), 
however. Edges between the ventricular blood pools and the myocardium were seen to be 
softer in the 5D images, and the ventricular blood signal relative to the septal signal was 
lower in the 5D images as well (Figure 34b). This analysis was only done for six of the 
nine image sets in the bSSFP cohort as the other three image sets were of too poor quality 
for the endomyocardial wall to be identified.  
8.3.4 Limited Dimension Reconstruction 
Reconstruction time was substantially lower with fewer cardiac phases. For the first 
data set, reconstruction of the full five-dimensional image using all 10 bins required 




approximately 16 hours of reconstruction time. Conversely, using 0, 1, 2, or 3 adjacent 
cardiac phases for the limited reconstruction, only 0.8, 2.3, 3.8, and 5.2 hours were needed, 
respectively (Figure 35). For the second data set, 40.5 hours were needed to reconstruct all 
24 phases, but the same times were needed in the limited reconstructions for this data set 
as in the first. 
Visual inspection of the images reconstructed using fewer frames showed overall 
agreement with full reconstruction (Figure 35), though some minor differences could be 
seen particularly in the case where only the diastatic phase was used. The differences were 
not qualitatively determined to affect the potential diagnostic performance of the images. 
Quantitative comparison of the limited reconstructions against the full reconstruction 
reinforced these observations for both subjects tested (Figure 36). Generally strong 
correlation and structural similarity were seen for all cases with comparison with the 
Figure 36: Similarity analysis of limited dimension reconstructions. Image sets reconstructed with limited 
cardiac dimension were compared against images reconstructed with all cardiac phases. For each volume, 
1000 random voxels were selected and the intensity was plotted against the intensity of the corresponding 
voxel in the control volume, and Pearson’s correlation coefficient was calculated. Additionally, the SSIM 




original; however, this was particularly true for the cases in which one or more adjacent 
bins were used—i.e., the ones which actually utilized a five-dimensional reconstruction 
rather than simply a four-dimensional reconstruction with retrospective cardiac gating. 
Correlation and similarity were seen to increase with more adjacent phases, though both 
quantitative measures showed quick convergence towards 1.0.  
8.4 Discussion 
Of the three acquisitions tested, it was observed that the ferumoxytol-enhanced, 
spoiled-GRE sequence performed substantially better at characterizing the coronary three-
dimensional geometry than either the non-contrast, bSSFP acquisition or the gadolinium-
enhanced, spoiled-GRE acquisition. No significant difference was observed between the 
latter two groups in terms of imaging quality. The ability to correctly calculate the EF 
compared to clinical standard protocol did lend confidence in the bSSFP acquisition as far 
as its ability to correctly resolve the cardiac phases. However, in general, neither of the two 
acquisitions tested on human patients were determined to be of sufficient quality for three-
dimensional segmentation of the coronary epicardial vasculature. 
Though the theoretical disadvantages of the continuous bSSFP approach were 
discussed previously, this result is still somewhat unexpected. Without the T2-prep pulse 
to amplify the myocardium-blood contrast, we would anticipate the image quality to be 
worse; without the saturation band on the anterior chest wall, we have fold-over artifacts 
manifesting as radial streaks which degrade the image. However, previously reported 
studies have shown relatively positive outcomes of this approach in comparison with 4D-
GRASP MRA [26, 27]. Though the gadolinium-enhanced GRE approach has not 




to the methodology used by Feng et al. which yielded comparable quality to 4D-GRASP 
[26]. It is possible that this discrepancy is due to the populations investigated, as Di Sopra 
et al. only tested this acquisition on healthy volunteers. Patients with CHD may have 
anomalous cardiac rhythms which are not handled well by PCA. The exact causes of this 
disparity cannot be determined at this time and thus require further investigation. However, 
the results reported previously by Feng et al. only revealed an equal level of quality 
between 5D-GRASP MRA and 4D-GRASP MRA. According to the conclusions of 
Chapter 7, this level of quality still would not be sufficient for full three-dimensional 
characterization, so it is not suspected that resolving this discrepancy alone would be 
enough.  
For the gadolinium-enhanced acquisition, the gadoteridol was administered as a 
bolus injection prior to the start of the scan, which resulted in the contrast between the 
blood pool and myocardium to lessen progressively as the contrast agent left the 
intravascular space. A potential correction for this would be a slow infusion of the 
gadolinium over the duration of the scan, to help maintain a constant level within the blood 
stream. Doing this was not possible in this study due to clinical limitations but may be an 
option in the future. 
With both the bSSFP and gadolinium-enhanced GRE acquisitions, the manner in 
which the images appeared unsuitable was very similar for both. Using relatively low 
values for the regularization parameters (~0.01) produced images which were 
exceptionally noisy. To compensate for this noise, the values ultimately used were quite 
high so that information could be more easily shared across the cardiac and respiratory 




averaging which removed finer details such as myocardial wall sharpness and vessel 
sharpness. To improve this, more initial information is needed to offload the reliance on 
the k-t SENSE algorithm; i.e., more samples are needed in each data set. Doing so in this 
clinical application was not possible, as only an eight minute window was allotted for the 
GRASP acquisition.  
The image quality seen in the ferumoxytol-enhanced acquisition was substantially 
better than the other two 5D-GRASP MRA techniques and was also higher than what was 
seen previously in self-navigation MRA or 4D-GRASP MRA. The majority of the 
epicardial vessels imaged were fully three-dimensionally characterized. Further 
modifications of the protocol, however, could improve this success rate. The heart-rates 
seen in the pigs was much higher than what is typically observed in humans—around 100 
to 140 bpm. Because of this, the number of cardiac phases that could be resolved was 
limited, meaning that more cardiac motion was captured within each phase. It is possible 
that imaging human patients with heart-rates closer to 40 to 70 bpm may automatically 
effect improvement due to the increased cardiac cycle resolution. Further improvement 
may come, again, from increasing the number of raw data points acquired, decreasing the 
number of segments acquired in each interleaf, and increasing the number of radial 
readouts per segment. Such changes would give an increased temporal and spatial 
resolution and reduce reliance on compressed sensing reconstruction to recover 
information from undersampled data. These changes would, of course, result in a longer 
scan time, however the spoiled-GRE acquisition employed with the ferumoxytol-enhanced 




The computational cost of the reconstructions was high. Some reconstructions 
would perform in as few as 12 hours, but for many the time needed would exceed 24 or 
even 30 hours. One reconstruction required over 40 hours to complete. The time and 
computational hardware needed for these calculations will certainly be a hurdle for full 
clinical implementation of these protocols. Whole-heart MRA is very frequently used in 
patients with CHD to aid in positioning and planning other sequences.  
The limited dimension reconstruction approach did show promising results. It was 
observed that reconstructing only the cardiac phase of interest with a limited number of 
adjacent phases—as few as three total phases—could produce images which were 
structurally identical to those acquired using the full data set. Due to the limited number of 
cardiac phases, reconstruction performed significantly faster, and could be completed in 
fewer than three hours. No differences were seen for the reconstruction times for the two 
subjects tested, which could suggest that the computational cost is constant for a set number 
of total bins. In practice, this timing should vary with acquisitions depending on 
regularization parameters and inherent continuity or discontinuity between physiologic 
states, however it does appear to be very largely dependent on the total dimensionality. It 
was not investigated here, but an obvious next step would be to investigate the same 
approach with a limited number of respiratory bins. Every reconstruction performed in this 
study used four reconstruction states, though it was generally observed that the best 
motion-compensation usually occurred at end-expiration. By using only this respiratory 
state and the one immediately adjacent, the total number of bins would be halved and could 




The early success seen with this limited reconstruction approach shows promise for 
several applications of cardiac-resolved MRA. For coronary three-dimensional 
segmentation, only one motion state is needed and is almost always present at diastasis 
during end-expiration. In a subject with 10 cardiac and 4 respiratory states, 40 total bins 
are acquired from the data. However, by reconstructing only the bin at diastasis and end-
inspiration and its immediate neighbors, the total number of bins can be reduced from 40 
to 6. Similarly, for the use case of calculating the EF in the patient, only the volumes located 
at end-diastole and end-systole are needed. With only immediately adjacent physiologic 
states, this requires only 12 total bins.  
It is important to note, however, that any dissimilarity observed between the limited 
dimension reconstructions and the full reconstructions does not necessarily imply that these 
shallow reconstructions are less accurate. The k-t SENSE algorithm utilizes a total 
variation–based compressed sensing reconstruction, which attempts to enforce continuity 
within dimensions. Ideally, this is used because all physiologic motions are continuous 
motions, however XD-GRASP is an inherently discrete approach to handling these 
motions. If a large amount of motion occurs between two adjacent physiologic bins, 
attempting to enforce continuity between them can result in images which are not 
necessarily representative of reality. It is, therefore, possible that the images reconstructed 
without any adjacent cardiac phases could be more accurate than those reconstructed using 
all cardiac phases. All that can be concluded here is the amount of similarity between these 
reconstructions, and further investigation of this would be useful in the future.  
Though the ferumoxytol-enhanced group showed success, there is still limitations 




issued a boxed warning for ferumoxytol following a series of adverse events in patients 
after its use [63]. Bolus injection of ferumoxytol was identified as a risk factor for these 
events, and therefore the FDA currently advises that it be administered as an infusion over 
15 minutes, which can add to the clinical overhead associated with the scan. However, 
because of its longevity in the patient, it is entirely possible to inject the agent into the 
patient well before they are actually on the scanner table. The potential for adverse events 
is still a cause for concern in its clinical use, and currently it is not FDA-approved for use 
in MRI except as an off-label drug. A recent multicenter study of off-label diagnostic use 
of ferumoxytol in MRI, however, concluded that diagnostic ferumoxytol use is well-
tolerated and not associated with any serious adverse events [64]. Lastly, the cost of 
ferumoxytol is significantly higher than gadolinium-based contrast agents, which may also 
be a hurdle to its clinical implementation. 
Another limitation to the techniques presented here is a lack of direct comparison 
of the anatomy measured here and a ground-truth measurement. For full validation of this 
approach, we would need to image the same subjects with CT or some invasive modality 
to determine if the MRI-derived anatomy is accurate. A phantom model could also be used 
to provide a known ground-truth for comparison, though such a model would necessarily 
be very complex. Such comparisons were determined to beyond the scope of the current 
study but would be necessary in the future. 
8.5 Conclusion 
The ability to retrospectively-gate cardiac temporal windows through 5D-GRASP 
MRA offers a substantial improvement for coronary MRA. Doing so, however, requires a 




these limitations, most magnetization preparatory pulses cannot be employed as this will 
preclude an adequate temporal resolution. It was observed that neither a non-contrast, 
bSSFP acquisition nor a gadolinium-enhanced, spoiled-GRE acquisition with continuous 
data sampling would be able to provide sufficient image quality for full coronary 
characterization in two cohorts of patients with CHD. A ferumoxytol-enhanced, spoiled-
GRE acquisition, however, showed preliminary success in a cohort of pigs. The time 
required to reconstruct these five-dimensional images was seen to be very high, though it 
could be reduced through use of a limited number of cardiac phases. If the clinical hurdles 





CHAPTER 9.  CONCLUSIONS AND FUTURE WORK 
9.1 Summary 
The determination of which patients with CAD will benefit from intervention is 
critically important for providing proper treatment, but the gold standard for this 
determination—FFR—is underutilized due to its invasive nature. MRI is particularly well-
suited for defining the boundary conditions needed for calculation of vFFR through CFD 
as it can measure both anatomy and flow velocity, directly. This thesis sought to further 
the development of MRI toward this overall objective. To do this, two aims were 
investigated: 
1) Determine if PCMR can provide the inlet flow boundary conditions necessary 
for calculation of vFFR. 
2) Determine if self-gated MRI can provide image quality sufficient for coronary 
geometry characterization. 
In Aim 1, it was determined that patient-specific time-averaged hyperemic flow is 
needed to define the inlet flow boundary condition to calculate vFFR. This has two 
important implications. The first is that only the time-averaged flow is necessary, meaning 
that the patient-specific time-averaged basal flow rate can be measured through PCMR and 
then scaled by CFR to adequately define the boundary condition. The second implication 
is that patient-specific CFR is necessary for an accurate vFFR calculation. Because CT is 
incapable of measuring patient-specific CFR, this imposes limitations on the potential of 
CT-derived vFFR. Once it was determined what flow information was necessary, PCMR 




that coronary arterial flow measurements obtained through PCMR both exhibit 
repeatability and are consistent with coronary sinus flow measurements, which have been 
previously validated. In Aim 2, different implementations of self-gated MRI were 
investigated for their potential in coronary MRA. It was seen that self-navigation MRI 
could not provide sufficient quality, and this was suspected to be due to how it handles 
motion-compensation. These suspicions were confirmed through paired comparison with 
4D-GRASP MRA, which showed significant improvement in image quality. 4D-GRASP 
MRA was still determined to not provide sufficient quality for calculation of vFFR due to 
its use of prospective cardiac-gating, and therefore 5D-GRASP MRA was investigated for 
its ability to retrospectively gate for both cardiac and respiratory motion. Three different 
implementations of 5D-GRASP MRA were considered, including a non-contrast bSSFP 
acquisition, a gadolinium-enhanced spoiled-GRE acquisition, and a ferumoxytol-enhanced 
spoiled-GRE acquisition. By far the best image quality of all self-gated MRI 
implementations tested was observed in the ferumoxytol-enhanced spoiled-GRE 
continuous acquisition with 5D-GRASP reconstruction, with full three-dimensional 
geometric characterization visible for most of the coronary vessels tested.   
The results of these studies helped advance coronary MRA, both in quantifying 
flow and geometry. The potential for utilizing these techniques for calculating vFFR is 
clinically significant as it provides a non-invasive alternative with a fully patient-specific 
computational model. This can help increase the use of FFR in evaluating patients with 




9.2 Future Work 
Though the coronary arterial flow measurements obtained through PCMR were 
seen to be internally consistent, some limitations to these measurements were discovered. 
The flow rate measured through PCMR is the summation of the blood flow moving through 
the vessel and the motion of the vessel itself over the course of the cardiac cycle. For time-
averaged flow rate, this vessel motion is not expected to significantly contribute to the net 
flow rate, so long as the ROI is maintained at a constant area. This can complicate flow 
rate measurements if adjacent tissues overlap with the ROI and its dimensions cannot be 
adjusted. Furthermore, this restricts PCMR from being used to quantify time-dependent 
coronary flow waveforms for use in simulations where time-dependent behavior is 
needed—such as in calculating wall shear stress or oscillatory shear index. Future work 
toward developing a more robust method for separating the flow velocity and vessel 
velocity would be useful both for simplifying the flow quantification process for vFFR and 
expanding the applications of PCMR elsewhere.  
The ferumoxytol-enhanced 5D-GRASP technique was observed to provide the best 
image quality of all the techniques tested, but further development into this is necessary. 
The sample size tested was very limited due to the current safety concerns of off-label 
diagnostic use of ferumoxytol in humans, but further tests into its safety could reduce these 
restrictions and allow for more thorough testing. This technique was also observed to be 
limited by the spatial and temporal resolutions, though both of these limitations are hard-
coded into the acquisition software and could not be changed. Further adjustment of these 
parameters and approval of the updated sequence would allow for testing of a more optimal 




Lastly, the combination of flow and anatomic measurements through MRI to 
develop a full non-invasive MRI-derived vFFR pipeline needs to be designed and tested 
against the invasive gold standard FFR to fully validate this methodology. This could be 
done through a complex phantom model designed to simulate the physiologic processes 





1. Mozaffarian, D., et al., Heart disease and stroke statistics--2015 update: a report 
from the American Heart Association. Circulation, 2015. 131(4): p. e29-322. 
 
2. Harold, J.G., et al., ACCF/AHA/SCAI 2013 update of the clinical competence 
statement on coronary artery interventional procedures: a report of the American 
College of Cardiology Foundation/American Heart Association/American College 
of Physicians Task Force on Clinical Competence and Training (Writing 
Committee to Revise the 2007 Clinical Competence Statement on Cardiac 
Interventional Procedures). J Am Coll Cardiol, 2013. 62(4): p. 357-96. 
 
3. Chen, T.-C., C.D. Fryar, and X. Li, Prevalence of uncontrolled risk factors for 
cardiovascular disease; United States, 1999-2010. 2012. 
 
4. Gould, K.L., K. Lipscomb, and G.W. Hamilton, Physiologic basis for assessing 
critical coronary stenosis. Instantaneous flow response and regional distribution 
during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol, 
1974. 33(1): p. 87-94. 
 
5. Shaw, L.J., et al., Optimal medical therapy with or without percutaneous coronary 
intervention to reduce ischemic burden: results from the Clinical Outcomes 
Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial 
nuclear substudy. Circulation, 2008. 117(10): p. 1283-91. 
 
6. Pijls, N.H., et al., Fractional flow reserve a useful index to evaluate the influence 
of an epicardial coronary stenosis on myocardial blood flow. Circulation, 1995. 
92(11): p. 3183-3193. 
 
7. Pijls, N.H., et al., Percutaneous coronary intervention of functionally 
nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol, 
2007. 49(21): p. 2105-11. 
 
8. Tonino, P.A., et al., Fractional flow reserve versus angiography for guiding 
percutaneous coronary intervention. New England Journal of Medicine, 2009. 
360(3): p. 213-224. 
 
9. De Bruyne, B., et al., Fractional flow reserve-guided PCI versus medical therapy 





10. Dattilo, P.B., et al., Contemporary patterns of fractional flow reserve and 
intravascular ultrasound use among patients undergoing percutaneous coronary 
intervention in the United States: Insights from the National Cardiovascular Data 
Registry. J Am Coll Cardiol, 2012. 60(22): p. 2337-9. 
 
11. Taylor, C.A., T.A. Fonte, and J.K. Min, Computational fluid dynamics applied to 
cardiac computed tomography for noninvasive quantification of fractional flow 
reserve: scientific basis. J Am Coll Cardiol, 2013. 61(22): p. 2233-41. 
 
12. Choy, J.S. and G.S. Kassab, Scaling of myocardial mass to flow and morphometry 
of coronary arteries. J Appl Physiol (1985), 2008. 104(5): p. 1281-6. 
 
13. Murray, C.D., The Physiological Principle of Minimum Work: I. The vascular 
System and the Cost of Blood Volume. Proc. of the NAS of USA, 1926. 12(3): p. 
207-214. 
 
14. Koo, B.K., et al., Diagnosis of ischemia-causing coronary stenoses by noninvasive 
fractional flow reserve computed from coronary computed tomographic 
angiograms. Results from the prospective multicenter DISCOVER-FLOW 
(Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional 
Flow Reserve) study. J Am Coll Cardiol, 2011. 58(19): p. 1989-97. 
 
15. Wilson, R.F., et al., Effects of adenosine on human coronary arterial circulation. 
Circulation, 1990. 82: p. 1595-1606. 
 
16. Ahn, S.G., et al., Discordance Between Fractional Flow Reserve and Coronary 
Flow Reserve: Insights From Intracoronary Imaging and Physiological 
Assessment. JACC Cardiovasc Interv, 2017. 10(10): p. 999-1007. 
 
17. Bryant, D., et al., Measurement of flow with NMR imaging using a gradient pulse 
and phase difference technique. J Comput Assist Tomogr, 1984. 8(4): p. 588-593. 
 
18. Firmin, D., et al., In vivo validation of MR velocity imaging. J Comput Assist 
Tomogr, 1987. 11(5): p. 751-756. 
 
19. Stehning, C., et al., Free-breathing whole-heart coronary MRA with 3D radial 






20. Piccini, D., et al., Spiral phyllotaxis: the natural way to construct a 3D radial 
trajectory in MRI. Magn Reson Med, 2011. 66(4): p. 1049-56. 
 
21. Piccini, D., et al., Respiratory self-navigation for whole-heart bright-blood 
coronary MRI: methods for robust isolation and automatic segmentation of the 
blood pool. Magn Reson Med, 2012. 68(2): p. 571-9. 
 
22. Piccini, D., et al., Respiratory self-navigated postcontrast whole-heart coronary 
MR angiography: initial experience in patients. Radiology, 2014. 270(2): p. 378-
86. 
 
23. Coppo, S., et al., Free-running 4D whole-heart self-navigated golden angle MRI: 
Initial results. Magn Reson Med, 2015. 74(5): p. 1306-16. 
 
24. Piccini, D., et al., Four-dimensional respiratory motion-resolved whole heart 
coronary MR angiography. Magn Reson Med, 2016. 
 
25. Feng, L., et al., XD-GRASP: Golden-angle radial MRI with reconstruction of extra 
motion-state dimensions using compressed sensing. Magn Reson Med, 2016. 75(2): 
p. 775-88. 
 
26. Feng, L., et al., 5D whole-heart sparse MRI. Magn Reson Med, 2018. 79(2): p. 826-
838. 
 
27. Di Sopra, L., et al., An automated approach to fully self-gated free-running cardiac 
and respiratory motion-resolved 5D whole-heart MRI. Magn Reson Med, 2019. 
82(6): p. 2118-2132. 
 
28. Hair, J.B., L.H. Timmins, and J. Oshinski. Magnetic Resonance Imaging - Derived 
Coronary Fractional Flow Reserve: Preliminary Results. in Society for Magnetic 
Resonance Angiography. 2016. Chicago, IL. 
 
29. Rosamond, W., et al., Heart disease and stroke statistics--2007 update: a report 
from the American Heart Association Statistics Committee and Stroke Statistics 
Subcommittee. Circulation, 2007. 115(5): p. e69-171. 
 
30. Cook, C.M., et al., Diagnostic Accuracy of Computed Tomography-Derived 






31. Hartlage, G.R., et al., Prediction of response to cardiac resynchronization therapy 
using left ventricular pacing lead position and cardiovascular magnetic resonance 
derived wall motion patterns: a prospective cohort study. J Cardiovasc Magn 
Reson, 2015. 17: p. 57. 
 
32. Yang, Q., et al., Contrast-enhanced whole-heart coronary magnetic resonance 
angiography at 3.0-T: a comparative study with X-ray angiography in a single 
center. J Am Coll Cardiol, 2009. 54(1): p. 69-76. 
 
33. Sethian, J.A., A fast marching level set method for monotonically advancing fronts. 
Proceedings of the National Academy of Sciences, 1996. 93(4): p. 1591-1595. 
 
34. Sethian, J.A., Level set methods and fast marching methods: evolving interfaces in 
computational geometry, fluid mechanics, computer vision, and materials science. 
Vol. 3. 1999: Cambridge university press. 
 
35. Antiga, L., B. Ene-Iordache, and A. Remuzzi, Computational geometry for patient-
specific reconstruction and meshing of blood vessels from MR and CT 
angiography. IEEE transactions on medical imaging, 2003. 22(5): p. 674-684. 
 
36. Samady, H., et al., Coronary artery wall shear stress is associated with progression 
and transformation of atherosclerotic plaque and arterial remodeling in patients 
with coronary artery disease. Circulation, 2011. 124(7): p. 779-88. 
 
37. Hung, O.Y., et al., Comprehensive Assessment of Coronary Plaque Progression 
With Advanced Intravascular Imaging, Physiological Measures, and Wall Shear 
Stress: A Pilot Double-Blinded Randomized Controlled Clinical Trial of Nebivolol 
Versus Atenolol in Nonobstructive Coronary Artery Disease. J Am Heart Assoc, 
2016. 5(1). 
 
38. Bland, J.M. and D.G. Altman, Statistical Methods for Assessing Agreement 
Between Two Methods of Clinical Measurement. The Lancet, 1986. 327(8476): p. 
307-310. 
 
39. Lin, L.I.K., A Concordance Correlation Coefficient to Evaluate Reproducibility. 
Biometrics, 1989. 45(1): p. 255-268. 
 






41. Morris, P.D., et al., Fast Virtual Fractional Flow Reserve Based Upon Steady-State 
Computational Fluid Dynamics Analysis: Results From the VIRTU-Fast Study. 
JACC Basic Transl Sci, 2017. 2(4): p. 434-446. 
 
42. Nakazato, R., et al., CFR and FFR assessment with PET and CTA: strengths and 
limitations. Curr Cardiol Rep, 2014. 16(5): p. 484. 
 
43. Levitt, M.H., Spin dynamics: basics of nuclear magnetic resonance. 2001: John 
Wiley & Sons. 
 
44. Moran, P.R., R. Moran, and N. Karstaedt, Verification and evaluation of internal 
flow and motion. True magnetic resonance imaging by the phase gradient 
modulation method. Radiology, 1985. 154(2): p. 433-441. 
 
45. Stankovic, Z., et al., 4D flow imaging with MRI. Cardiovasc Diagn Ther, 2014. 
4(2): p. 173-92. 
 
46. Nayler, G., D. Firmin, and D. Longmore, Blood flow imaging by cine magnetic 
resonance. J Comput Assist Tomogr, 1986. 10(5): p. 715-722. 
 
47. Sakuma, H., et al., MR measurement of coronary blood flow. Journal of Magnetic 
Resonance Imaging: An Official Journal of the International Society for Magnetic 
Resonance in Medicine, 1999. 10(5): p. 728-733. 
 
48. Kawada, N., et al., Hypertrophic cardiomyopathy: MR measurement of coronary 
blood flow and vasodilator flow reserve in patients and healthy subjects. 
Radiology, 1999. 211(1): p. 129-135. 
 
49. Hundley, W.G., et al., Assessment of coronary arterial restenosis with phase-
contrast magnetic resonance imaging measurements of coronary flow reserve. 
Circulation, 2000. 101(20): p. 2375-2381. 
 
50. Lam, A., et al., Performance of 3D, navigator echo-gated, contrast-enhanced, 
magnetic resonance coronary vein imaging in patients undergoing CRT. Journal of 
Interventional Cardiac Electrophysiology, 2014. 41(2): p. 155-160. 
 
51. Heiberg, E., et al., Design and validation of Segment-freely available software for 





52. Johnson, K., P. Sharma, and J. Oshinski, Coronary artery flow measurement using 
navigator echo gated phase contrast magnetic resonance velocity mapping at 3.0 
T. J Biomech, 2008. 41(3): p. 595-602. 
 
53. Ganz, W., et al., Measurement of coronary sinus blood flow by continuous 
thermodilution in man. Circulation, 1971. 44(2): p. 181-195. 
 
54. Piccini, D., Respiratory Self-Navigation for Free Breathing Whole-Heart Coronary 
MR Imaging with High Isotropic Spatial Resolution in Patients. 2013. 
 
55. Agarwal, A., et al., Age- and Lesion-Related Comorbidity Burden Among US Adults 
With Congenital Heart Disease: A Population-Based Study. J Am Heart Assoc, 
2019. 8(20): p. e013450. 
 
56. Chandarana, H., et al., Respiratory Motion-Resolved Compressed Sensing 
Reconstruction of Free-Breathing Radial Acquisition for Dynamic Liver Magnetic 
Resonance Imaging. Invest Radiol, 2015. 50(11): p. 749-56. 
 
57. Chandarana, H., et al., Free-breathing contrast-enhanced multiphase MRI of the 
liver using a combination of compressed sensing, parallel imaging, and golden-
angle radial sampling. Investigative radiology, 2013. 48(1). 
 
58. Feng, L., et al., Golden‐angle radial sparse parallel MRI: combination of 
compressed sensing, parallel imaging, and golden‐angle radial sampling for fast 
and flexible dynamic volumetric MRI. Magnetic resonance in medicine, 2014. 
72(3): p. 707-717. 
 
59. Pang, J., et al., ECG and navigator-free four-dimensional whole-heart coronary 
MRA for simultaneous visualization of cardiac anatomy and function. Magn Reson 
Med, 2014. 72(5): p. 1208-17. 
 
60. Bieri, O. and K. Scheffler, Fundamentals of balanced steady state free precession 
MRI. J Magn Reson Imaging, 2013. 38(1): p. 2-11. 
 
61. Prince, M.R., et al., A pilot investigation of new superparamagnetic iron oxide 
(ferumoxytol) as a contrast agent for cardiovascular MRI. Journal of X-ray science 
and technology, 2003. 11(4): p. 231-240. 
 
62. Tweedle, M., et al., Reaction of gadolinium chelates with endogenously available 





63. Administration., U.S.F.a.D. FDA Drug Safety Communication: FDA strengthens 
warnings and changes prescribing instructions to decrease the risk of serious 
allergic reactions with anemia drug Feraheme (ferumoxytol). 2015  [cited 2020 
March 7]; Available from: 
http://www.fda.gov/Drugs/DrugSafety/ucm440138.htm. 
 
64. Nguyen, K.-L., et al., Multicenter Safety and Practice for Off-Label Diagnostic Use 
of Ferumoxytol in MRI. Radiology, 2019. 293(3): p. 554-564. 
 
 
